{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 2412, "items": [{"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T21:16:33Z", "timestamp": 1525727793384}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 4, 1]]}, "DOI": "10.21236/ada416967", "type": "report", "created": {"date-parts": [[2017, 8, 17]], "date-time": "2017-08-17T15:25:51Z", "timestamp": 1502983551000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effects of CSK Homologous Kinase Overexpression on HER2/Neu-Mediated Signal Transduction Pathways in Breast Cancer Cells"], "prefix": "10.21236", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 17]], "date-time": "2017-08-17T15:25:51Z", "timestamp": 1502983551000}, "score": 30.073513, "subtitle": [""], "issued": {"date-parts": [[2003, 4, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada416967"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T20:58:40Z", "timestamp": 1525726720324}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2004, 4, 1]]}, "DOI": "10.21236/ada425671", "type": "report", "created": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T13:28:28Z", "timestamp": 1502717308000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effects of CSK Homologous Kinase Overexpression on HER2/Neu-Mediated Signal Transduction Pathways in Breast Cancer Cells"], "prefix": "10.21236", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T13:28:28Z", "timestamp": 1502717308000}, "score": 30.073513, "subtitle": [""], "issued": {"date-parts": [[2004, 4, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada425671"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T20:46:37Z", "timestamp": 1525725997510}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2005, 4, 1]]}, "DOI": "10.21236/ada436916", "type": "report", "created": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T18:53:01Z", "timestamp": 1502477581000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effects of Csk Homologous Kinase Overexpression on HER2/Neu-Mediated Signal Transduction Pathways in Breast Cancer Cells"], "prefix": "10.21236", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T18:53:02Z", "timestamp": 1502477582000}, "score": 30.073513, "subtitle": [""], "issued": {"date-parts": [[2005, 4, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada436916"}, {"indexed": {"date-parts": [[2018, 5, 27]], "date-time": "2018-05-27T23:42:33Z", "timestamp": 1527464553172}, "reference-count": 0, "publisher": "Termedia Sp. z.o.o.", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["wo"], "published-print": {"date-parts": [[2015]]}, "DOI": "10.5114/wo.2014.47127", "type": "journal-article", "created": {"date-parts": [[2015, 2, 27]], "date-time": "2015-02-27T09:08:50Z", "timestamp": 1425028130000}, "page": "1-6", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Review Cancer stem cells in haematological malignancies"], "prefix": "10.5114", "volume": "1A", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Jakub", "family": "Golab", "sequence": "additional", "affiliation": []}], "member": "3061", "container-title": ["Wsp\u00f3\u0142czesna Onkologia"], "link": [{"URL": "http://www.termedia.pl/doi_ft/10.5114/wo.2014.47127", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 8, 11]], "date-time": "2016-08-11T11:15:00Z", "timestamp": 1470914100000}, "score": 30.073513, "issued": {"date-parts": [[2015]]}, "references-count": 0, "alternative-id": ["47127"], "URL": "http://dx.doi.org/10.5114/wo.2014.47127", "ISSN": ["1428-2526"], "issn-type": [{"value": "1428-2526", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T14:19:43Z", "timestamp": 1523974783062}, "publisher-location": "Cham", "reference-count": 0, "publisher": "Springer International Publishing", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-46906-5", "type": "book", "created": {"date-parts": [[2016, 9, 23]], "date-time": "2016-09-23T09:42:15Z", "timestamp": 1474623735000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology"], "prefix": "10.1007", "author": [{"given": "Witold", "family": "Lasek", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["SpringerBriefs in Immunology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-46906-5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-46906-5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 9, 23]], "date-time": "2016-09-23T09:42:15Z", "timestamp": 1474623735000}, "score": 30.073513, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319469058", "9783319469065"], "references-count": 0, "URL": "http://dx.doi.org/10.1007/978-3-319-46906-5", "ISSN": ["2194-2773", "2194-2781"], "issn-type": [{"value": "2194-2773", "type": "print"}, {"value": "2194-2781", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T14:19:43Z", "timestamp": 1523974783488}, "publisher-location": "Cham", "reference-count": 120, "publisher": "Springer International Publishing", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-46906-5_1", "type": "book-chapter", "created": {"date-parts": [[2016, 9, 23]], "date-time": "2016-09-23T09:42:15Z", "timestamp": 1474623735000}, "page": "1-19", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Biology of IL-12"], "prefix": "10.1007", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Witold", "family": "Lasek", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 9, 24]]}, "reference": [{"issue": "1", "key": "1_CR1", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1016/j.cyto.2015.07.026", "volume": "76", "author": "K Abdi", "year": "2015", "unstructured": "Abdi K, Singh NJ (2015) Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines. Cytokine 76(1):53\u201357. doi: 10.1016/j.cyto.2015.07.026", "journal-title": "Cytokine"}, {"issue": "7", "key": "1_CR2", "doi-asserted-by": "publisher", "first-page": "e6119", "DOI": "10.1371/journal.pone.0006119", "volume": "4", "author": "I Airoldi", "year": "2009", "unstructured": "Airoldi I, Di Carlo E, Cocco C, Caci E, Cilli M, Sorrentino C, Sozzi G, Ferrini S, Rosini S, Bertolini G et al (2009) IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. PLoS ONE 4(7):e6119. doi: 10.1371/journal.pone.0006119", "journal-title": "PLoS ONE"}, {"issue": "9", "key": "1_CR3", "doi-asserted-by": "publisher", "first-page": "584", "DOI": "10.1038/nrc3349", "volume": "12", "author": "GK Alderton", "year": "2012", "unstructured": "Alderton GK (2012) Immunology: TIM3 suppresses antitumour DCs. Nat Rev Cancer 12(9):584. doi: 10.1038/nrc3349", "journal-title": "Nat Rev Cancer"}, {"key": "1_CR4", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1111/j.1749-6632.1996.tb52664.x", "volume": "795", "author": "AL Angiolillo", "year": "1996", "unstructured": "Angiolillo AL, Sgadari C, Tosato G (1996) A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Ann N Y Acad Sci 795:158\u2013167", "journal-title": "Ann N Y Acad Sci"}, {"issue": "27", "key": "1_CR5", "doi-asserted-by": "crossref", "first-page": "17109", "DOI": "10.1074/jbc.273.27.17109", "volume": "273", "author": "HA Baden", "year": "1998", "unstructured": "Baden HA, Sarma SP, Kapust RB, Byrd RA, Waugh DS (1998) The amino-terminal domain of human STAT4. Overproduction, purification, and biophysical characterization. J Biol Chem 273(27):17109\u201317114", "journal-title": "J Biol Chem"}, {"key": "1_CR6", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1186/1479-5876-6-26", "volume": "6", "author": "LA Basile", "year": "2008", "unstructured": "Basile LA, Gallaher TK, Shibata D, Miller JD, Douer D (2008) Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice. J Transl Med 6:26. doi: 10.1186/1479-5876-6-26", "journal-title": "J Transl Med"}, {"issue": "2", "key": "1_CR7", "first-page": "271", "volume": "71", "author": "KR Bastos", "year": "2002", "unstructured": "Bastos KR, Alvarez JM, Marinho CR, Rizzo LV, Lima MR (2002) Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. J Leukoc Biol 71(2):271\u2013278", "journal-title": "J Leukoc Biol"}, {"issue": "5", "key": "1_CR8", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1089/jir.2007.0128", "volume": "27", "author": "KR Bastos", "year": "2007", "unstructured": "Bastos KR, Barboza R, Sardinha L, Russo M, Alvarez JM, Lima MR (2007) Role of endogenous IFN-gamma in macrophage programming induced by IL-12 and IL-18. J Interferon Cytokine Res 27(5):399\u2013410. doi: 10.1089/jir.2007.0128", "journal-title": "J Interferon Cytokine Res"}, {"issue": "2", "key": "1_CR9", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1016/S0002-9440(10)65149-8", "volume": "155", "author": "G Bellone", "year": "1999", "unstructured": "Bellone G, Turletti A, Artusio E, Mareschi K, Carbone A, Tibaudi D, Robecchi A, Emanuelli G, Rodeck U (1999) Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol 155(2):537\u2013547", "journal-title": "Am J Pathol"}, {"issue": "3", "key": "1_CR10", "doi-asserted-by": "publisher", "first-page": "2045", "DOI": "10.4049/jimmunol.0800276", "volume": "183", "author": "S Brahmachari", "year": "2009", "unstructured": "Brahmachari S, Pahan K (2009) Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 183(3):2045\u20132058. doi: 10.4049/jimmunol.0800276", "journal-title": "J Immunol"}, {"issue": "8", "key": "1_CR11", "first-page": "4943", "volume": "162", "author": "WE Carson", "year": "1999", "unstructured": "Carson WE, Yu H, Dierksheide J, Pfeffer K, Bouchard P, Clark R, Durbin J, Baldwin AS, Peschon J, Johnson PR et al (1999) A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 162(8):4943\u20134951", "journal-title": "J Immunol"}, {"issue": "12", "key": "1_CR12", "doi-asserted-by": "publisher", "first-page": "10235", "DOI": "10.1007/s11033-012-1899-y", "volume": "39", "author": "H Chen", "year": "2012", "unstructured": "Chen H, Cheng S, Wang J, Cao C, Bunjhoo H, Xiong W, Xu Y (2012a) Interleukin-12B rs3212227 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 39(12):10235\u201310242. doi: 10.1007/s11033-012-1899-y", "journal-title": "Mol Biol Rep"}, {"issue": "1", "key": "1_CR13", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/j.imlet.2012.09.002", "volume": "148", "author": "X Chen", "year": "2012", "unstructured": "Chen X, Du Y, Huang Z (2012b) CD4+\u00a0CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity. Immunol Lett 148(1):83\u201389. doi: 10.1016/j.imlet.2012.09.002", "journal-title": "Immunol Lett"}, {"issue": "1\u20132", "key": "1_CR14", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1016/j.jneuroim.2007.01.012", "volume": "185", "author": "X Cheng", "year": "2007", "unstructured": "Cheng X, Zhao Z, Ventura E, Gran B, Shindler KS, Rostami A (2007) The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. J Neuroimmunol 185(1\u20132):75\u201386. doi: 10.1016/j.jneuroim.2007.01.012", "journal-title": "J Neuroimmunol"}, {"issue": "14", "key": "1_CR15", "doi-asserted-by": "publisher", "first-page": "3890", "DOI": "10.1182/blood-2011-05-357111", "volume": "118", "author": "FZ Chowdhury", "year": "2011", "unstructured": "Chowdhury FZ, Ramos HJ, Davis LS, Forman J, Farrar JD (2011) IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo. Blood 118(14):3890\u20133900. doi: 10.1182/blood-2011-05-357111", "journal-title": "Blood"}, {"issue": "1", "key": "1_CR16", "first-page": "128", "volume": "153", "author": "AO Chua", "year": "1994", "unstructured": "Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK et al (1994) Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 153(1):128\u2013136", "journal-title": "J Immunol"}, {"issue": "6", "key": "1_CR17", "doi-asserted-by": "publisher", "first-page": "952", "DOI": "10.1016/j.immuni.2007.11.014", "volume": "27", "author": "EY Chung", "year": "2007", "unstructured": "Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M, Han J, Silverstein R, Selleri L, Ma X (2007) Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27(6):952\u2013964. doi: 10.1016/j.immuni.2007.11.014", "journal-title": "Immunity"}, {"issue": "7169", "key": "1_CR18", "doi-asserted-by": "publisher", "first-page": "566", "DOI": "10.1038/nature06306", "volume": "450", "author": "LW Collison", "year": "2007", "unstructured": "Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566\u2013569. doi: 10.1038/nature06306", "journal-title": "Nature"}, {"issue": "3", "key": "1_CR19", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1159/000363502", "volume": "164", "author": "L Cosmi", "year": "2014", "unstructured": "Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F (2014) Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin. Int Arch Allergy Immunol 164(3):171\u2013177. doi: 10.1159/000363502", "journal-title": "Int Arch Allergy Immunol"}, {"issue": "6", "key": "1_CR20", "doi-asserted-by": "publisher", "first-page": "381", "DOI": "10.1097/MD.0b013e3181fdd832", "volume": "89", "author": "L Beaucoudrey de", "year": "2010", "unstructured": "de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, Al-Muhsen S, Janniere L, Rose Y, de Suremain M et al (2010) Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89(6):381\u2013402. doi: 10.1097/MD.0b013e3181fdd832", "journal-title": "Medicine (Baltimore)"}, {"issue": "16", "key": "1_CR21", "doi-asserted-by": "publisher", "first-page": "4677", "DOI": "10.1158/1078-0432.CCR-07-0776", "volume": "13", "author": "M Vecchio Del", "year": "2007", "unstructured": "Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13(16):4677\u20134685. doi: 10.1158/1078-0432.CCR-07-0776", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "1_CR22", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1007/BF02698035", "volume": "24", "author": "D Derin", "year": "2007", "unstructured": "Derin D, Soydinc HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E (2007) Serum IL-8 and IL-12 levels in breast cancer. Med Oncol 24(2):163\u2013168", "journal-title": "Med Oncol"}, {"key": "1_CR23", "unstructured": "Durali D, de Goer de Herve MG, Giron-Michel J, Azzarone B, Delfraissy JF, Taoufik Y (2003) In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 102(12):4084\u20134089. doi: 10.1182/blood-2003-02-0518", "DOI": "10.1182/blood-2003-02-0518", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "1_CR24", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1016/S0304-3835(01)00526-2", "volume": "168", "author": "T Felzmann", "year": "2001", "unstructured": "Felzmann T, Buchberger M, Lehner M, Printz D, Kircheis R, Wagner E, Gadner H, Holter W (2001) Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes. Cancer Lett 168(2):145\u2013154", "journal-title": "Cancer Lett"}, {"issue": "2", "key": "1_CR25", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1016/j.imlet.2010.08.002", "volume": "133", "author": "E Ferretti", "year": "2010", "unstructured": "Ferretti E, Di Carlo E, Cocco C, Ribatti D, Sorrentino C, Ognio E, Montagna D, Pistoia V, Airoldi I (2010) Direct inhibition of human acute myeloid leukemia cell growth by IL-12. Immunol Lett 133(2):99\u2013105. doi: 10.1016/j.imlet.2010.08.002", "journal-title": "Immunol Lett"}, {"issue": "11", "key": "1_CR26", "first-page": "6014", "volume": "161", "author": "WE Fogler", "year": "1998", "unstructured": "Fogler WE, Volker K, Watanabe M, Wigginton JM, Roessler P, Brunda MJ, Ortaldo JR, Wiltrout RH (1998) Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas. J Immunol 161(11):6014\u20136021", "journal-title": "J Immunol"}, {"issue": "1", "key": "1_CR27", "doi-asserted-by": "publisher", "first-page": "200", "DOI": "10.1002/eji.1830250133", "volume": "25", "author": "S Gillessen", "year": "1995", "unstructured": "Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK (1995) Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25(1):200\u2013206. doi: 10.1002/eji.1830250133", "journal-title": "Eur J Immunol"}, {"issue": "1", "key": "1_CR28", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1023/A:1008266321552", "volume": "9", "author": "J Golab", "year": "1998", "unstructured": "Golab J, Stoklosa T, Zagozdzon R, Kaca A, Giermasz A, Pojda Z, Machaj E, Dabrowska A, Feleszko W, Lasek W et al (1998a) G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice. Ann Oncol 9(1):63\u201369", "journal-title": "Ann Oncol"}, {"issue": "2", "key": "1_CR29", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1159/000029978", "volume": "19", "author": "J Golab", "year": "1998", "unstructured": "Golab J, Stoklosa T, Zagozdzon R, Kaca A, Kulchitska LA, Feleszko W, Kawiak J, Hoser G, Glowacka E, Dabrowska A et al (1998b) Granulocyte-macrophage colony-stimulating factor potentiates antitumor activity of interleukin-12 in melanoma model in mice. Tumour Biol 19(2):77\u201387", "journal-title": "Tumour Biol"}, {"issue": "3", "key": "1_CR30", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/S0165-2478(00)00178-4", "volume": "72", "author": "J Golab", "year": "2000", "unstructured": "Golab J, Zagozdzon Stoklosal T, Kaminski R, Kozar K, Jakobisiak M (2000) Direct stimulation of macrophages by IL-12 and IL-18\u2013a bridge too far? Immunol Lett 72(3):153\u2013157", "journal-title": "Immunol Lett"}, {"issue": "5", "key": "1_CR31", "first-page": "537", "volume": "3", "author": "J Golab", "year": "1999", "unstructured": "Golab J, Zagozdzon R (1999) Antitumor effects of interleukin-12 in pre-clinical and early clinical studies (review). Int J Mol Med 3(5):537\u2013544", "journal-title": "Int J Mol Med"}, {"issue": "11", "key": "1_CR32", "first-page": "4387", "volume": "91", "author": "J Golab", "year": "1998", "unstructured": "Golab J, Zagozdzon R, Stoklosa T, Jakobisiak M, Pojda Z, Machaj E (1998c) Erythropoietin prevents the development of interleukin-12-induced anemia and thrombocytopenia but does not decrease its antitumor activity in mice. Blood 91(11):4387\u20134388", "journal-title": "Blood"}, {"issue": "4", "key": "1_CR33", "first-page": "1341", "volume": "91", "author": "JA Gollob", "year": "1998", "unstructured": "Gollob JA, Murphy EA, Mahajan S, Schnipper CP, Ritz J, Frank DA (1998) Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1. Blood 91(4):1341\u20131354", "journal-title": "Blood"}, {"issue": "1", "key": "1_CR34", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.4049/jimmunol.167.1.221", "volume": "167", "author": "U Grohmann", "year": "2001", "unstructured": "Grohmann U, Belladonna ML, Vacca C, Bianchi R, Fallarino F, Orabona C, Fioretti MC, Puccetti P (2001) Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma. J Immunol 167(1):221\u2013227", "journal-title": "J Immunol"}, {"issue": "8", "key": "1_CR35", "first-page": "3593", "volume": "158", "author": "U Grohmann", "year": "1997", "unstructured": "Grohmann U, Bianchi R, Ayroldi E, Belladonna ML, Surace D, Fioretti MC, Puccetti P (1997) A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J Immunol 158(8):3593\u20133602", "journal-title": "J Immunol"}, {"issue": "3", "key": "1_CR36", "doi-asserted-by": "publisher", "first-page": "789", "DOI": "10.3390/ijms11030789", "volume": "11", "author": "T Hamza", "year": "2010", "unstructured": "Hamza T, Barnett JB, Li B (2010) Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 11(3):789\u2013806. doi: 10.3390/ijms11030789", "journal-title": "Int J Mol Sci"}, {"key": "1_CR37", "doi-asserted-by": "publisher", "first-page": "948098", "DOI": "10.1155/2012/948098", "volume": "2012", "author": "NB Hao", "year": "2012", "unstructured": "Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, Yang SM (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012:948098. doi: 10.1155/2012/948098", "journal-title": "Clin Dev Immunol"}, {"issue": "5", "key": "1_CR38", "doi-asserted-by": "publisher", "first-page": "749", "DOI": "10.1093/infdis/jit126", "volume": "208", "author": "J Held", "year": "2013", "unstructured": "Held J, Preusse C, Doser A, Richter L, Heppner FL, Stenzel W (2013) Enhanced acute immune response in IL-12p35-/- mice is followed by accelerated distinct repair mechanisms in Staphylococcus aureus-induced murine brain abscess. J Infect Dis 208(5):749\u2013760. doi: 10.1093/infdis/jit126", "journal-title": "J Infect Dis"}, {"issue": "3", "key": "1_CR39", "doi-asserted-by": "publisher", "first-page": "659", "DOI": "10.1002/eji.1830260323", "volume": "26", "author": "C Heufler", "year": "1996", "unstructured": "Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuler G (1996) Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 26(3):659\u2013668. doi: 10.1002/eji.1830260323", "journal-title": "Eur J Immunol"}, {"issue": "5107", "key": "1_CR40", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1126/science.8097338", "volume": "260", "author": "CS Hsieh", "year": "1993", "unstructured": "Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O\u2019Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260(5107):547\u2013549", "journal-title": "Science"}, {"issue": "5", "key": "1_CR41", "doi-asserted-by": "crossref", "first-page": "1755", "DOI": "10.1084/jem.181.5.1755", "volume": "181", "author": "NG Jacobson", "year": "1995", "unstructured": "Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, Murphy KM (1995) Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 181(5):1755\u20131762", "journal-title": "J Exp Med"}, {"issue": "12", "key": "1_CR42", "first-page": "1189", "volume": "18", "author": "A Jafarzadeh", "year": "2015", "unstructured": "Jafarzadeh A, Minaee K, Farsinejad AR, Nemati M, Khosravimashizi A, Daneshvar H, Mohammadi MM, Sheikhi A, Ghaderi A (2015) Evaluation of the circulating levels of IL-12 and IL-33 in patients with breast cancer: influences of the tumor stages and cytokine gene polymorphisms. Iran J Basic Med Sci 18(12):1189\u20131198", "journal-title": "Iran J Basic Med Sci"}, {"issue": "2\u20133", "key": "1_CR43", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/j.imlet.2003.08.005", "volume": "90", "author": "M Jakobisiak", "year": "2003", "unstructured": "Jakobisiak M, Lasek W, Golab J (2003) Natural mechanisms protecting against cancer. Immunol Lett 90(2\u20133):103\u2013122", "journal-title": "Immunol Lett"}, {"issue": "9", "key": "1_CR44", "doi-asserted-by": "publisher", "first-page": "6763", "DOI": "10.1074/jbc.M112.436675", "volume": "288", "author": "R Jalah", "year": "2013", "unstructured": "Jalah R, Rosati M, Ganneru B, Pilkington GR, Valentin A, Kulkarni V, Bergamaschi C, Chowdhury B, Zhang GM, Beach RK et al (2013) The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production. J Biol Chem 288(9):6763\u20136776. doi: 10.1074/jbc.M112.436675", "journal-title": "J Biol Chem"}, {"issue": "1", "key": "1_CR45", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1093/intimm/12.1.103", "volume": "12", "author": "K Kawamoto", "year": "2000", "unstructured": "Kawamoto K, Paliwal V, Ramabhadran R, Szczepanik M, Tsuji RF, Matsuda H, Askenase PW (2000) IL-12 is produced by antigen-presenting cells stimulated with soluble alphabeta TCR and restores impaired T(h)1 responses. Int Immunol 12(1):103\u2013112", "journal-title": "Int Immunol"}, {"key": "1_CR46", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1111/j.1749-6632.1996.tb52660.x", "volume": "795", "author": "BL Kelsall", "year": "1996", "unstructured": "Kelsall BL, Stuber E, Neurath M, Strober W (1996) Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann NY Acad Sci 795:116\u2013126", "journal-title": "Ann NY Acad Sci"}, {"issue": "12", "key": "1_CR47", "doi-asserted-by": "publisher", "first-page": "4746", "DOI": "10.1172/JCI58814", "volume": "121", "author": "SP Kerkar", "year": "2011", "unstructured": "Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM et al (2011) IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J Clin Invest 121(12):4746\u20134757. doi: 10.1172/JCI58814", "journal-title": "J Clin Invest"}, {"issue": "7", "key": "1_CR48", "doi-asserted-by": "publisher", "first-page": "1369", "DOI": "10.1038/mt.2013.58", "volume": "21", "author": "SP Kerkar", "year": "2013", "unstructured": "Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, Pan JH, Palmer DC, Morgan RA, Rosenberg SA et al (2013) Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Mol Ther 21(7):1369\u20131377. doi: 10.1038/mt.2013.58", "journal-title": "Mol Ther"}, {"issue": "3", "key": "1_CR49", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1084/jem.170.3.827", "volume": "170", "author": "M Kobayashi", "year": "1989", "unstructured": "Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170(3):827\u2013845", "journal-title": "J Exp Med"}, {"key": "1_CR50", "doi-asserted-by": "publisher", "first-page": "1223", "DOI": "10.1038/ncomms2223", "volume": "3", "author": "M Kuka", "year": "2012", "unstructured": "Kuka M, Munitic I, Ashwell JD (2012) Identification and characterization of polyclonal alphabeta-T cells with dendritic cell properties. Nat Commun 3:1223. doi: 10.1038/ncomms2223", "journal-title": "Nat Commun"}, {"issue": "4", "key": "1_CR51", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1007/s00262-003-0449-9", "volume": "53", "author": "W Lasek", "year": "2004", "unstructured": "Lasek W, Basak G, Switaj T, Jakubowska AB, Wysocki PJ, Mackiewicz A, Drela N, Jalili A, Kaminski R, Kozar K et al (2004) Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice. Cancer Immunol Immunother 53(4):363\u2013372. doi: 10.1007/s00262-003-0449-9", "journal-title": "Cancer Immunol Immunother"}, {"issue": "2", "key": "1_CR52", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1007/s002620050408", "volume": "45", "author": "W Lasek", "year": "1997", "unstructured": "Lasek W, Feleszko W, Golab J, Stoklosa T, Marczak M, Dabrowska A, Malejczyk M, Jakobisiak M (1997) Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor alpha in mice. Cancer Immunol Immunother 45(2):100\u2013108", "journal-title": "Cancer Immunol Immunother"}, {"issue": "5", "key": "1_CR53", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1007/s00262-014-1523-1", "volume": "63", "author": "W Lasek", "year": "2014", "unstructured": "Lasek W, Zagozdzon R, Jakobisiak M (2014) Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother 63(5):419\u2013435. doi: 10.1007/s00262-014-1523-1", "journal-title": "Cancer Immunol Immunother"}, {"issue": "11", "key": "1_CR54", "doi-asserted-by": "publisher", "first-page": "3017", "DOI": "10.1002/eji.201040539", "volume": "40", "author": "MH Lexberg", "year": "2010", "unstructured": "Lexberg MH, Taubner A, Albrecht I, Lepenies I, Richter A, Kamradt T, Radbruch A, Chang HD (2010) IFN-gamma and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol 40(11):3017\u20133027. doi: 10.1002/eji.201040539", "journal-title": "Eur J Immunol"}, {"issue": "3", "key": "1_CR55", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1016/j.ymthe.2003.11.022", "volume": "9", "author": "S Li", "year": "2004", "unstructured": "Li S, Xia X, Mellieon FM, Liu J, Steele S (2004) Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy. Mol Ther 9(3):347\u2013354. doi: 10.1016/j.ymthe.2003.11.022", "journal-title": "Mol Ther"}, {"issue": "1", "key": "1_CR56", "first-page": "116", "volume": "154", "author": "P Ling", "year": "1995", "unstructured": "Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154(1):116\u2013127", "journal-title": "J Immunol"}, {"issue": "6", "key": "1_CR57", "doi-asserted-by": "publisher", "first-page": "e218", "DOI": "10.1016/S1470-2045(12)70582-X", "volume": "14", "author": "BE Lippitz", "year": "2013", "unstructured": "Lippitz BE (2013) Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol 14(6):e218\u2013228. doi: 10.1016/S1470-2045(12)70582-X", "journal-title": "Lancet Oncol"}, {"issue": "8", "key": "1_CR58", "doi-asserted-by": "publisher", "first-page": "1265", "DOI": "10.1084/jem.20030026", "volume": "198", "author": "J Liu", "year": "2003", "unstructured": "Liu J, Cao S, Herman LM, Ma X (2003) Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J Exp Med 198(8):1265\u20131276. doi: 10.1084/jem.20030026", "journal-title": "J Exp Med"}, {"issue": "53", "key": "1_CR59", "doi-asserted-by": "publisher", "first-page": "55609", "DOI": "10.1074/jbc.M406565200", "volume": "279", "author": "J Liu", "year": "2004", "unstructured": "Liu J, Guan X, Tamura T, Ozato K, Ma X (2004) Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem 279(53):55609\u201355617. doi: 10.1074/jbc.M406565200", "journal-title": "J Biol Chem"}, {"issue": "3", "key": "1_CR60", "doi-asserted-by": "publisher", "first-page": "431", "DOI": "10.1016/j.surg.2012.05.035", "volume": "152", "author": "E Luedke", "year": "2012", "unstructured": "Luedke E, Jaime-Ramirez AC, Bhave N, Roda J, Choudhary MM, Kumar B, Teknos TN, Carson WE 3rd (2012) Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines. Surgery 152(3):431\u2013440. doi: 10.1016/j.surg.2012.05.035", "journal-title": "Surgery"}, {"issue": "11", "key": "1_CR61", "doi-asserted-by": "crossref", "first-page": "6775", "DOI": "10.4049/jimmunol.172.11.6775", "volume": "172", "author": "RJ Lund", "year": "2004", "unstructured": "Lund RJ, Chen Z, Scheinin J, Lahesmaa R (2004) Early target genes of IL-12 and STAT4 signaling in th cells. J Immunol 172(11):6775\u20136782", "journal-title": "J Immunol"}, {"key": "1_CR62", "unstructured": "Ma TT, Wu BT, Lin Y, Xiong HY, Wang Q, Li ZW, Cheng F, Tu ZG (2015a) IL-12 could induce monocytic tumor cells directional differentiation. Mol Cell Biochem 402 (1-2):157-169. doi: 10.1007/s11010-014-2323-9", "DOI": "10.1007/s11010-014-2323-9", "doi-asserted-by": "publisher"}, {"key": "1_CR63", "unstructured": "Ma X, Yan W, Zheng H, Du Q, Zhang L, Ban Y, Li N, Wei F (2015b) Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Res 4. doi: 10.12688/f1000research.7010.1", "DOI": "10.12688/f1000research.7010.1", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "1_CR64", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1084/jem.183.1.147", "volume": "183", "author": "X Ma", "year": "1996", "unstructured": "Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G (1996) The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 183(1):147\u2013157", "journal-title": "J Exp Med"}, {"issue": "10", "key": "1_CR65", "doi-asserted-by": "publisher", "first-page": "2329", "DOI": "10.1158/1078-0432.CCR-16-0224", "volume": "22", "author": "M Mandai", "year": "2016", "unstructured": "Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I (2016) Dual Faces of IFNgamma in cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity. Clin Cancer Res 22(10):2329\u20132334. doi: 10.1158/1078-0432.CCR-16-0224", "journal-title": "Clin Cancer Res"}, {"issue": "7", "key": "1_CR66", "doi-asserted-by": "crossref", "first-page": "3992", "DOI": "10.4049/jimmunol.174.7.3992", "volume": "174", "author": "E Marcenaro", "year": "2005", "unstructured": "Marcenaro E, Della Chiesa M, Bellora F, Parolini S, Millo R, Moretta L, Moretta A (2005) IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 174(7):3992\u20133998", "journal-title": "J Immunol"}, {"issue": "9", "key": "1_CR67", "first-page": "4298", "volume": "160", "author": "BL McRae", "year": "1998", "unstructured": "McRae BL, Semnani RT, Hayes MP, van Seventer GA (1998) Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 160(9):4298\u20134304", "journal-title": "J Immunol"}, {"issue": "1", "key": "1_CR68", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1007/s13277-012-0578-x", "volume": "34", "author": "A Memarian", "year": "2013", "unstructured": "Memarian A, Nourizadeh M, Masoumi F, Tabrizi M, Emami AH, Alimoghaddam K, Hadjati J, Mirahmadian M, Jeddi-Tehrani M (2013) Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia. Tumour Biol 34(1):531\u2013542. doi: 10.1007/s13277-012-0578-x", "journal-title": "Tumour Biol"}, {"issue": "2", "key": "1_CR69", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/0167-5699(92)90140-3", "volume": "13", "author": "DM Merberg", "year": "1992", "unstructured": "Merberg DM, Wolf SF, Clark SC (1992) Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol Today 13(2):77\u201378. doi: 10.1016/0167-5699(92)90140-3", "journal-title": "Immunol Today"}, {"key": "1_CR70", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.4137/CMO.S11292", "volume": "7", "author": "MA Michelin", "year": "2013", "unstructured": "Michelin MA, Abdalla DR, Aleixo AA, Murta EF (2013) Peripheral helper lymphocytes produce interleukin 12 in cancer patients. Clin Med Insights Oncol 7:75\u201381. doi: 10.4137/CMO.S11292", "journal-title": "Clin Med Insights Oncol"}, {"issue": "3", "key": "1_CR71", "doi-asserted-by": "publisher", "first-page": "1523", "DOI": "10.3892/ol.2015.3470", "volume": "10", "author": "MA Michelin", "year": "2015", "unstructured": "Michelin MA, Montes L, Nomelini RS, Abdalla DR, Aleixo AA, Murta EF (2015) Interleukin-12 in patients with cancer is synthesized by peripheral helper T lymphocytes. Oncol Lett 10(3):1523\u20131526. doi: 10.3892/ol.2015.3470", "journal-title": "Oncol Lett"}, {"issue": "8", "key": "1_CR72", "doi-asserted-by": "publisher", "first-page": "1445", "DOI": "10.4161/onci.21318", "volume": "1", "author": "AJ Michielsen", "year": "2012", "unstructured": "Michielsen AJ, Ryan EJ, O\u2019Sullivan JN (2012) Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment. Oncoimmunology 1(8):1445\u20131447. doi: 10.4161/onci.21318", "journal-title": "Oncoimmunology"}, {"issue": "2", "key": "1_CR73", "doi-asserted-by": "publisher", "first-page": "322", "DOI": "10.1189/jlb.1203641", "volume": "76", "author": "M Mitsuhashi", "year": "2004", "unstructured": "Mitsuhashi M, Liu J, Cao S, Shi X, Ma X (2004) Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J Leukoc Biol 76(2):322\u2013332. doi: 10.1189/jlb.1203641", "journal-title": "J Leukoc Biol"}, {"issue": "12", "key": "1_CR74", "doi-asserted-by": "crossref", "first-page": "1996", "DOI": "10.1038/sj.leu.2402308", "volume": "15", "author": "J Miyauchi", "year": "2001", "unstructured": "Miyauchi J (2001) In vitro effects of interleukin-12 on the growth of blast progenitors in acute myelogenous leukemia. Leukemia 15(12):1996\u20131998", "journal-title": "Leukemia"}, {"issue": "13", "key": "1_CR75", "doi-asserted-by": "publisher", "first-page": "2351", "DOI": "10.1084/jem.20120944", "volume": "209", "author": "J Ni", "year": "2012", "unstructured": "Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A (2012) Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 209(13):2351\u20132365. doi: 10.1084/jem.20120944", "journal-title": "J Exp Med"}, {"key": "1_CR76", "author": "G Nizzoli", "year": "2013", "unstructured": "Nizzoli G, Krietsch J, Weick A, Steinfelder S, Facciotti F, Gruarin P, Bianco A, Steckel B, Moro M, Crosti MC et al (2013) Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T cell responses. Blood. doi: 10.1182/blood-2013-04-495424", "journal-title": "Blood", "DOI": "10.1182/blood-2013-04-495424", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "1_CR77", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1016/S1074-7613(00)00070-4", "volume": "13", "author": "B Oppmann", "year": "2000", "unstructured": "Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5):715\u2013725", "journal-title": "Immunity"}, {"issue": "2", "key": "1_CR78", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1006/cimm.1999.1589", "volume": "198", "author": "T Otani", "year": "1999", "unstructured": "Otani T, Nakamura S, Toki M, Motoda R, Kurimoto M, Orita K (1999) Identification of IFN-gamma-producing cells in IL-12/IL-18-treated mice. Cell Immunol 198(2):111\u2013119. doi: 10.1006/cimm.1999.1589", "journal-title": "Cell Immunol"}, {"issue": "2", "key": "1_CR79", "doi-asserted-by": "publisher", "first-page": "218", "DOI": "10.1006/jsre.1995.1034", "volume": "58", "author": "I Pappo", "year": "1995", "unstructured": "Pappo I, Tahara H, Robbins PD, Gately MK, Wolf SF, Barnea A, Lotze MT (1995) Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy. J Surg Res 58(2):218\u2013226. doi: 10.1006/jsre.1995.1034", "journal-title": "J Surg Res"}, {"issue": "7", "key": "1_CR80", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1172/JCI15950", "volume": "110", "author": "R Parihar", "year": "2002", "unstructured": "Parihar R, Dierksheide J, Hu Y, Carson WE (2002) IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest 110(7):983\u2013992. doi: 10.1172/JCI15950", "journal-title": "J Clin Invest"}, {"key": "1_CR81", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1007/978-3-319-15774-0_2", "volume": "850", "author": "S Piconese", "year": "2015", "unstructured": "Piconese S, Barnaba V (2015) Stability of regulatory T cells undermined or endorsed by different type-1 cytokines. Adv Exp Med Biol 850:17\u201330. doi: 10.1007/978-3-319-15774-0_2", "journal-title": "Adv Exp Med Biol"}, {"issue": "28", "key": "1_CR82", "doi-asserted-by": "publisher", "first-page": "4809", "DOI": "10.1200/JCO.2008.21.3579", "volume": "27", "author": "V Pistoia", "year": "2009", "unstructured": "Pistoia V, Cocco C, Airoldi I (2009) Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene in human B-cell malignancies. J Clin Oncol 27(28):4809\u20134816. doi: 10.1200/JCO.2008.21.3579", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "1_CR83", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1097/MD.0b013e31828a01f9", "volume": "92", "author": "C Prando", "year": "2013", "unstructured": "Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, AlSum Z, Al-Jumaah S, Al-Hajjar S, Frayha H et al (2013) Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) 92(2):109\u2013122. doi: 10.1097/MD.0b013e31828a01f9", "journal-title": "Medicine (Baltimore)"}, {"issue": "24", "key": "1_CR84", "doi-asserted-by": "crossref", "first-page": "14002", "DOI": "10.1073/pnas.93.24.14002", "volume": "93", "author": "DH Presky", "year": "1996", "unstructured": "Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U (1996) A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A 93(24):14002\u201314007", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "2", "key": "1_CR85", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1016/j.cyto.2014.11.018", "volume": "71", "author": "RT Robinson", "year": "2015", "unstructured": "Robinson RT (2015) IL12Rbeta1: the cytokine receptor that we used to know. Cytokine 71(2):348\u2013359. doi: 10.1016/j.cyto.2014.11.018", "journal-title": "Cytokine"}, {"issue": "5", "key": "1_CR86", "first-page": "1323", "volume": "83", "author": "AR Rossi", "year": "1994", "unstructured": "Rossi AR, Pericle F, Rashleigh S, Janiec J, Djeu JY (1994) Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood 83(5):1323\u20131328", "journal-title": "Blood"}, {"issue": "4", "key": "1_CR87", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1016/S1074-7613(00)00045-5", "volume": "13", "author": "O Schulz", "year": "2000", "unstructured": "Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, Sher A, Reis e Sousa C (2000) CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13(4):453\u2013462", "journal-title": "Immunity"}, {"issue": "4", "key": "1_CR88", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1158/1535-7163.MCT-15-0706", "volume": "15", "author": "L Shi", "year": "2016", "unstructured": "Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C (2016) Targeting Androgen Receptor (AR)\u2192 IL12A signal enhances efficacy of Sorafenib plus NK cells immunotherapy to better suppress HCC progression. Mol Cancer Ther 15(4):731\u2013742. doi: 10.1158/1535-7163.MCT-15-0706", "journal-title": "Mol Cancer Ther"}, {"issue": "26", "key": "1_CR89", "doi-asserted-by": "publisher", "first-page": "23582", "DOI": "10.1074/jbc.M111.249235", "volume": "286", "author": "AM Smith", "year": "2011", "unstructured": "Smith AM, Qualls JE, O\u2019Brien K, Balouzian L, Johnson PF, Schultz-Cherry S, Smale ST, Murray PJ (2011) A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3. J Biol Chem 286(26):23582\u201323590. doi: 10.1074/jbc.M111.249235", "journal-title": "J Biol Chem"}, {"issue": "12", "key": "1_CR90", "doi-asserted-by": "publisher", "first-page": "1223", "DOI": "10.1111/apm.12288", "volume": "122", "author": "N Stanilov", "year": "2014", "unstructured": "Stanilov N, Miteva L, Jovchev J, Cirovski G, Stanilova S (2014) The prognostic value of preoperative serum levels of IL-12p40 and IL-23 for survival of patients with colorectal cancer. APMIS 122(12):1223\u20131229. doi: 10.1111/apm.12288", "journal-title": "APMIS"}, {"issue": "17", "key": "1_CR91", "doi-asserted-by": "crossref", "first-page": "6808", "DOI": "10.1073/pnas.87.17.6808", "volume": "87", "author": "AS Stern", "year": "1990", "unstructured": "Stern AS, Podlaski FJ, Hulmes JD, Pan YC, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R et al (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci U S A 87(17):6808\u20136812", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "2", "key": "1_CR92", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1016/j.cyto.2015.01.030", "volume": "75", "author": "L Sun", "year": "2015", "unstructured": "Sun L, He C, Nair L, Yeung J, Egwuagu CE (2015) Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 75(2):249\u2013255. doi: 10.1016/j.cyto.2015.01.030", "journal-title": "Cytokine"}, {"issue": "4", "key": "1_CR93", "doi-asserted-by": "publisher", "first-page": "490", "DOI": "10.1200/JCO.2012.45.2052", "volume": "31", "author": "K Suzuki", "year": "2013", "unstructured": "Suzuki K, Kadota K, Sima CS, Nitadori J, Rusch VW, Travis WD, Sadelain M, Adusumilli PS (2013) Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor beta2 (IL-12Rbeta2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol 31(4):490\u2013498. doi: 10.1200/JCO.2012.45.2052", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "1_CR94", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1620/tjem.185.223", "volume": "185", "author": "S Suzuki", "year": "1998", "unstructured": "Suzuki S, Umezu Y, Saijo Y, Satoh G, Abe Y, Satoh K, Nukiwa T (1998) Exogenous recombinant human IL-12 augments MHC class I antigen expression on human cancer cells in vitro. Tohoku J Exp Med 185(3):223\u2013226", "journal-title": "Tohoku J Exp Med"}, {"issue": "5", "key": "1_CR95", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1084/jem.185.5.817", "volume": "185", "author": "SJ Szabo", "year": "1997", "unstructured": "Szabo SJ, Dighe AS, Gubler U, Murphy KM (1997) Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 185(5):817\u2013824", "journal-title": "J Exp Med"}, {"issue": "6587", "key": "1_CR96", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1038/382171a0", "volume": "382", "author": "WE Thierfelder", "year": "1996", "unstructured": "Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC et al (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382(6587):171\u2013174. doi: 10.1038/382171a0", "journal-title": "Nature"}, {"issue": "4", "key": "1_CR97", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1016/0955-2235(92)90016-B", "volume": "4", "author": "G Trinchieri", "year": "1992", "unstructured": "Trinchieri G, Wysocka M, D\u2019Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J (1992) Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 4(4):355\u2013368", "journal-title": "Prog Growth Factor Res"}, {"issue": "10", "key": "1_CR98", "doi-asserted-by": "publisher", "first-page": "1329", "DOI": "10.1002/humu.22380", "volume": "34", "author": "E Vosse van de", "year": "2013", "unstructured": "van de Vosse E, Haverkamp MH, Ramirez-Alejo N, Martinez-Gallo M, Blancas-Galicia L, Metin A, Garty BZ, Sun-Tan C, Broides A, de Paus RA et al (2013) IL-12Rbeta1 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat 34(10):1329\u20131339. doi: 10.1002/humu.22380", "journal-title": "Hum Mutat"}, {"issue": "5", "key": "1_CR99", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1186/ar1227", "volume": "6", "author": "AV Villarino", "year": "2004", "unstructured": "Villarino AV, Hunter CA (2004) Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27. Arthritis Res Ther 6(5):225\u2013233. doi: 10.1186/ar1227", "journal-title": "Arthritis Res Ther"}, {"issue": "8", "key": "1_CR100", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1093/jnci/87.8.581", "volume": "87", "author": "EE Voest", "year": "1995", "unstructured": "Voest EE, Kenyon BM, O\u2019Reilly MS, Truitt G, D\u2019Amato RJ, Folkman J (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87(8):581\u2013586", "journal-title": "J Natl Cancer Inst"}, {"issue": "18", "key": "1_CR101", "doi-asserted-by": "publisher", "first-page": "2238", "DOI": "10.1016/j.vaccine.2013.03.003", "volume": "31", "author": "JM Wang", "year": "2013", "unstructured": "Wang JM, Ma CJ, Li GY, Wu XY, Thayer P, Greer P, Smith AM, High KP, Moorman JP, Yao ZQ (2013) Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection. Vaccine 31(18):2238\u20132245. doi: 10.1016/j.vaccine.2013.03.003", "journal-title": "Vaccine"}, {"issue": "1\u20132", "key": "1_CR102", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1007/s11010-016-2687-0", "volume": "415", "author": "Q Wang", "year": "2016", "unstructured": "Wang Q, Cheng F, Ma TT, Xiong HY, Li ZW, Xie CL, Liu CY, Tu ZG (2016a) Interleukin-12 inhibits the hepatocellular carcinoma growth by inducing macrophage polarization to the M1-like phenotype through downregulation of Stat-3. Mol Cell Biochem 415(1\u20132):157\u2013168. doi: 10.1007/s11010-016-2687-0", "journal-title": "Mol Cell Biochem"}, {"issue": "6", "key": "1_CR103", "doi-asserted-by": "publisher", "first-page": "1343", "DOI": "10.1002/eji.201546095", "volume": "46", "author": "X Wang", "year": "2016", "unstructured": "Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G, Chen G, Hou C, Ma N, Shen B et al (2016b) A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice. Eur J Immunol 46(6):1343\u20131350. doi: 10.1002/eji.201546095", "journal-title": "Eur J Immunol"}, {"issue": "3", "key": "1_CR104", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1159/000323923", "volume": "3", "author": "R Wehner", "year": "2011", "unstructured": "Wehner R, Dietze K, Bachmann M, Schmitz M (2011) The bidirectional crosstalk between human dendritic cells and natural killer cells. J Innate Immun 3(3):258\u2013263. doi: 10.1159/000323923", "journal-title": "J Innate Immun"}, {"issue": "6", "key": "1_CR105", "doi-asserted-by": "publisher", "first-page": "1071", "DOI": "10.1189/jlb.2A0414-206RR", "volume": "97", "author": "WC Wei", "year": "2015", "unstructured": "Wei WC, Liu CP, Yang WC, Shyur LF, Sheu JH, Chen SS, Yang NS (2015) Mammalian target of rapamycin complex 2 (mTORC2) regulates LPS-induced expression of IL-12 and IL-23 in human dendritic cells. J Leukoc Biol 97(6):1071\u20131080. doi: 10.1189/jlb.2A0414-206RR", "journal-title": "J Leukoc Biol"}, {"issue": "11", "key": "1_CR106", "doi-asserted-by": "publisher", "first-page": "1705", "DOI": "10.1517/14712598.7.11.1705", "volume": "7", "author": "JM Weiss", "year": "2007", "unstructured": "Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH (2007) Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 7(11):1705\u20131721. doi: 10.1517/14712598.7.11.1705", "journal-title": "Expert Opin Biol Ther"}, {"issue": "8", "key": "1_CR107", "doi-asserted-by": "crossref", "first-page": "1053", "DOI": "10.1093/intimm/13.8.1053", "volume": "13", "author": "AK Wesa", "year": "2001", "unstructured": "Wesa AK, Galy A (2001) IL-1 beta induces dendritic cells to produce IL-12. Int Immunol 13(8):1053\u20131061", "journal-title": "Int Immunol"}, {"issue": "2", "key": "1_CR108", "doi-asserted-by": "publisher", "first-page": "400", "DOI": "10.1006/bbrc.1999.0479", "volume": "257", "author": "K Yamamoto", "year": "1999", "unstructured": "Yamamoto K, Shibata F, Miura O, Kamiyama R, Hirosawa S, Miyasaka N (1999) Physical interaction between interleukin-12 receptor beta 2 subunit and Jak2 tyrosine kinase: Jak2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor beta 2 via amino-terminus. Biochem Biophys Res Commun 257(2):400\u2013404. doi: 10.1006/bbrc.1999.0479", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "4", "key": "1_CR109", "doi-asserted-by": "publisher", "first-page": "1271", "DOI": "10.1172/JCI59806", "volume": "122", "author": "ZZ Yang", "year": "2012", "unstructured": "Yang ZZ, Grote DM, Ziesmer SC, Niki T, Hirashima M, Novak AJ, Witzig TE, Ansell SM (2012) IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma. J Clin Invest 122(4):1271\u20131282. doi: 10.1172/JCI59806", "journal-title": "J Clin Invest"}, {"issue": "3", "key": "1_CR110", "first-page": "1483", "volume": "161", "author": "T Yoshimoto", "year": "1998", "unstructured": "Yoshimoto T, Nagai N, Ohkusu K, Ueda H, Okamura H, Nakanishi K (1998) LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta\u00a0+\u00a0T cells. J Immunol 161(3):1483\u20131492", "journal-title": "J Immunol"}, {"issue": "4", "key": "1_CR111", "doi-asserted-by": "publisher", "first-page": "640", "DOI": "10.3889/oamjms.2015.106", "volume": "3", "author": "SS Youssef", "year": "2015", "unstructured": "Youssef SS, Mohammad MM, Ezz-El-Arab LR (2015) Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor Markers. Open Access Maced J Med Sci 3(4):640\u2013644. doi: 10.3889/oamjms.2015.106", "journal-title": "Open Access Maced J Med Sci"}, {"issue": "21", "key": "1_CR112", "doi-asserted-by": "publisher", "first-page": "3362", "DOI": "10.1080/15384101.2015.1093703", "volume": "14", "author": "S Yu", "year": "2015", "unstructured": "Yu S, Jia L, Zhang Y, Zhong J, Yang B, Wu C (2015) IL-12 induced the generation of IL-21- and IFN-gamma-co-expressing poly-functional CD4+\u00a0T cells from human naive CD4+\u00a0T cells. Cell Cycle 14(21):3362\u20133372. doi: 10.1080/15384101.2015.1093703", "journal-title": "Cell Cycle"}, {"issue": "3", "key": "1_CR113", "doi-asserted-by": "publisher", "first-page": "176", "DOI": "10.3109/08977194.2012.678843", "volume": "30", "author": "AE Yuzhalin", "year": "2012", "unstructured": "Yuzhalin AE, Kutikhin AG (2012) Interleukin-12: clinical usage and molecular markers of cancer susceptibility. Growth Factors 30(3):176\u2013191. doi: 10.3109/08977194.2012.678843", "journal-title": "Growth Factors"}, {"issue": "6D", "key": "1_CR114", "first-page": "4493", "volume": "17", "author": "R Zagozdzon", "year": "1997", "unstructured": "Zagozdzon R, Stoklosa T, Golab J, Giermasz A, Dabrowska A, Lasek W, Jakobisiak M (1997) Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model. Anticancer Res 17(6D):4493\u20134498", "journal-title": "Anticancer Res"}, {"issue": "2", "key": "1_CR115", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1097/00002371-199308000-00012", "volume": "14", "author": "HJ Zeh 3rd", "year": "1993", "unstructured": "Zeh HJ 3rd, Hurd S, Storkus WJ, Lotze MT (1993) Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J Immunother Emphasis Tumor Immunol 14(2):155\u2013161", "journal-title": "J Immunother Emphasis Tumor Immunol"}, {"issue": "5", "key": "1_CR116", "doi-asserted-by": "publisher", "first-page": "e19664", "DOI": "10.1371/journal.pone.0019664", "volume": "6", "author": "Y Zhang", "year": "2011", "unstructured": "Zhang Y, Ma CJ, Wang JM, Ji XJ, Wu XY, Jia ZS, Moorman JP, Yao ZQ (2011) Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection. PLoS ONE 6(5):e19664. doi: 10.1371/journal.pone.0019664", "journal-title": "PLoS ONE"}, {"issue": "7", "key": "1_CR117", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1089/dna.2008.0845", "volume": "28", "author": "B Zhao", "year": "2009", "unstructured": "Zhao B, Meng LQ, Huang HN, Pan Y, Xu QQ (2009) A novel functional polymorphism, 16974 A/C, in the interleukin-12-3\u2019 untranslated region is associated with risk of glioma. DNA Cell Biol 28(7):335\u2013341. doi: 10.1089/dna.2008.0845", "journal-title": "DNA Cell Biol"}, {"issue": "6", "key": "1_CR118", "doi-asserted-by": "crossref", "first-page": "2385", "DOI": "10.1128/MCB.24.6.2385-2396.2004", "volume": "24", "author": "L Zhou", "year": "2004", "unstructured": "Zhou L, Nazarian AA, Smale ST (2004) Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol Cell Biol 24(6):2385\u20132396", "journal-title": "Mol Cell Biol"}, {"key": "1_CR119", "author": "XD Zhu", "year": "2013", "unstructured": "Zhu XD, Sun HC, Xu HX, Kong LQ, Chai ZT, Lu L, Zhang JB, Gao DM, Wang WQ, Zhang W et al (2013) Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models. Angiogenesis. doi: 10.1007/s10456-013-9357-6", "journal-title": "Angiogenesis", "DOI": "10.1007/s10456-013-9357-6", "doi-asserted-by": "publisher"}, {"issue": "9", "key": "1_CR120", "doi-asserted-by": "crossref", "first-page": "6073", "DOI": "10.1074/jbc.272.9.6073", "volume": "272", "author": "J Zou", "year": "1997", "unstructured": "Zou J, Presky DH, Wu CY, Gubler U (1997) Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J Biol Chem 272(9):6073\u20136077", "journal-title": "J Biol Chem"}], "container-title": ["Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology", "SpringerBriefs in Immunology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-46906-5_1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T23:32:34Z", "timestamp": 1498347154000}, "score": 30.073513, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319469058", "9783319469065"], "references-count": 120, "URL": "http://dx.doi.org/10.1007/978-3-319-46906-5_1", "relation": {"cites": []}, "ISSN": ["2194-2773", "2194-2781"], "issn-type": [{"value": "2194-2773", "type": "print"}, {"value": "2194-2781", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T14:19:43Z", "timestamp": 1523974783507}, "publisher-location": "Cham", "reference-count": 115, "publisher": "Springer International Publishing", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-46906-5_3", "type": "book-chapter", "created": {"date-parts": [[2016, 9, 23]], "date-time": "2016-09-23T09:42:15Z", "timestamp": 1474623735000}, "page": "43-75", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Clinical Trials with IL-12 in Cancer Immunotherapy"], "prefix": "10.1007", "author": [{"given": "Witold", "family": "Lasek", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 9, 24]]}, "reference": [{"key": "3_CR1", "unstructured": "Alatrash G, Hutson TE, Molto L, Richmond A, Nemec C, Mekhail T, Elson P, Tannenbaum C, Olencki T, Finke J, Bukowski RM (2004) Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma. J Clin Oncol 22 (14):2891\u2013900. doi: 10.1200/JCO.2004.10.045", "DOI": "10.1200/JCO.2004.10.045", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "3_CR2", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1007/s00005-007-0025-7", "volume": "55", "author": "HK Alexander", "year": "2007", "unstructured": "Alexander HK, Booy EP, Xiao W, Ezzati P, Baust H, Los M (2007) Selected technologies to control genes and their products for experimental and clinical purposes. Arch Immunol Ther Exp (Warsz) 55(3):139\u2013149. doi: 10.1007/s00005-007-0025-7", "journal-title": "Arch Immunol Ther Exp (Warsz)"}, {"issue": "3", "key": "3_CR3", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1016/j.ygyno.2014.03.571", "volume": "133", "author": "RD Alvarez", "year": "2014", "unstructured": "Alvarez RD, Sill MW, Davidson SA, Muller CY, Bender DP, DeBernardo RL, Behbakht K, Huh WK (2014) A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study. Gynecol Oncol 133(3):433\u2013438. doi: 10.1016/j.ygyno.2014.03.571", "journal-title": "Gynecol Oncol"}, {"key": "3_CR4", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1186/2052-8426-2-27", "volume": "2", "author": "MH Amer", "year": "2014", "unstructured": "Amer MH (2014) Gene therapy for cancer: present status and future perspective. Mol Cell Ther 2:27. doi: 10.1186/2052-8426-2-27", "journal-title": "Mol Cell Ther"}, {"issue": "1", "key": "3_CR5", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1182/blood.V99.1.67", "volume": "99", "author": "SM Ansell", "year": "2002", "unstructured": "Ansell SM, Witzig TE, Kurtin PJ, Sloan JA, Jelinek DF, Howell KG, Markovic SN, Habermann TM, Klee GG, Atherton PJ, Erlichman C (2002) Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-hodgkin lymphoma. Blood 99(1):67\u201374", "journal-title": "Blood"}, {"issue": "20 Pt 1", "key": "3_CR6", "doi-asserted-by": "publisher", "first-page": "6056", "DOI": "10.1158/1078-0432.CCR-06-1245", "volume": "12", "author": "SM Ansell", "year": "2006", "unstructured": "Ansell SM, Geyer SM, Maurer MJ, Kurtin PJ, Micallef IN, Stella P, Etzell P, Novak AJ, Erlichman C, Witzig TE (2006) Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin\u2019s lymphoma patients. Clin Cancer Res 12(20 Pt 1):6056\u20136063. doi: 10.1158/1078-0432.CCR-06-1245", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "3_CR7", "doi-asserted-by": "publisher", "first-page": "360", "DOI": "10.1038/gt.2009.159", "volume": "17", "author": "K Anwer", "year": "2010", "unstructured": "Anwer K, Barnes MN, Fewell J, Lewis DH, Alvarez RD (2010) Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer. Gene Ther 17(3):360\u2013369. doi: 10.1038/gt.2009.159", "journal-title": "Gene Ther"}, {"key": "3_CR8", "author": "K Anwer", "year": "2013", "unstructured": "Anwer K, Kelly FJ, Chu C, Fewell JG, Lewis D, Alvarez RD (2013) Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer. Gynecol Oncol. doi: 10.1016/j.ygyno.2013.07.081", "journal-title": "Gynecol Oncol", "DOI": "10.1016/j.ygyno.2013.07.081", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "3_CR9", "first-page": "409", "volume": "3", "author": "MB Atkins", "year": "1997", "unstructured": "Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML (1997) Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res 3(3):409\u2013417", "journal-title": "Clin Cancer Res"}, {"key": "3_CR10", "unstructured": "Au BC, Liu Y, Huang J, Neller M, Arruda A, Rothe M, Paul G, Schambach A, Barber DL, Minden MD, Paige CJ, Medin J (2015) Pre-clinical preparation and validation of tumor cell-based IL-12 immunotherapy for acute myeloid leukemia. In: ASGCT 18th annual meeting, New Orleans, LA, p abstr. 413", "DOI": "10.1016/S1525-0016(16)34022-9", "doi-asserted-by": "crossref"}, {"issue": "7", "key": "3_CR11", "doi-asserted-by": "publisher", "first-page": "749", "DOI": "10.1097/CJI.0b013e3180de4ce8", "volume": "30", "author": "DE Avigan", "year": "2007", "unstructured": "Avigan DE, Vasir B, George DJ, Oh WK, Atkins MB, McDermott DF, Kantoff PW, Figlin RA, Vasconcelles MJ, Xu Y, Kufe D, Bukowski RM (2007) Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. J Immunother 30(7):749\u2013761. doi: 10.1097/CJI.0b013e3180de4ce8", "journal-title": "J Immunother"}, {"key": "3_CR12", "unstructured": "Avigan D, Rosenblatt J, Kufe D (2012) Dendritic/tumor fusion cells as cancer vaccines. Semin Oncol 39(3):287\u2013295. doi: 10.1053/j.seminoncol.2012.02.003", "DOI": "10.1053/j.seminoncol.2012.02.003", "doi-asserted-by": "publisher"}, {"key": "3_CR13", "unstructured": "Bagarazzi ML, Yan J, Morrow MP, Shen X, Parker RL, Lee JC, Giffear M, Pankhong P, Khan AS, Broderick KE, Knott C, Lin F, Boyer JD, Draghia-Akli R, White CJ, Kim JJ, Weiner DB, Sardesai NY (2012) Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med 4(155):155ra138. doi: 10.1126/scitranslmed.3004414", "DOI": "10.1126/scitranslmed.3004414", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "3_CR14", "first-page": "75", "volume": "4", "author": "E Bajetta", "year": "1998", "unstructured": "Bajetta E, Del Vecchio M, Mortarini R, Nadeau R, Rakhit A, Rimassa L, Fowst C, Borri A, Anichini A, Parmiani G (1998) Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin Cancer Res 4(1):75\u201385", "journal-title": "Clin Cancer Res"}, {"issue": "7", "key": "3_CR15", "doi-asserted-by": "publisher", "first-page": "1137", "DOI": "10.1007/s00262-013-1434-6", "volume": "62", "author": "JC Becker", "year": "2013", "unstructured": "Becker JC, Andersen MH, Schrama D, Thor Straten P (2013) Immune-suppressive properties of the tumor microenvironment. Cancer Immunol Immunother 62(7):1137\u20131148. doi: 10.1007/s00262-013-1434-6", "journal-title": "Cancer Immunol Immunother"}, {"issue": "11", "key": "3_CR16", "doi-asserted-by": "publisher", "first-page": "2983", "DOI": "10.1158/1535-7163.MCT-09-0820", "volume": "8", "author": "TS Bekaii-Saab", "year": "2009", "unstructured": "Bekaii-Saab TS, Roda JM, Guenterberg KD, Ramaswamy B, Young DC, Ferketich AK, Lamb TA, Grever MR, Shapiro CL, Carson WE 3rd (2009) A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies. Mol Cancer Ther 8(11):2983\u20132991. doi: 10.1158/1535-7163.MCT-09-0820", "journal-title": "Mol Cancer Ther"}, {"key": "3_CR17", "unstructured": "Bhatia S, Iyer J, Ibrani D, Blom A, Byrd D, Parvathaneni U, Diep T, Le MH, Pierce RH, Heller R, Daud A, Nghiem P (2015) Intratumoral delivery of Interleukin-12 DNA via in vivo electroporation leads to regression of injected and non-injected tumors in merkel cell carcinoma: final results of a phase 2 study. In: European cancer congress 2015, p abstr. 504", "DOI": "10.1016/S0959-8049(16)30306-9", "doi-asserted-by": "crossref"}, {"issue": "8", "key": "3_CR18", "doi-asserted-by": "publisher", "first-page": "3383", "DOI": "10.1172/JCI68395", "volume": "123", "author": "BM Carreno", "year": "2013", "unstructured": "Carreno BM, Becker-Hapak M, Huang A, Chan M, Alyasiry A, Lie WR, Aft RL, Cornelius LA, Trinkaus KM, Linette GP (2013) IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J Clin Invest 123(8):3383\u20133394. doi: 10.1172/JCI68395", "journal-title": "J Clin Invest"}, {"issue": "2", "key": "3_CR19", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1089/hum.2015.137", "volume": "27", "author": "M Cavazzana", "year": "2016", "unstructured": "Cavazzana M, Six E, Lagresle-Peyrou C, Andre-Schmutz I, Hacein-Bey-Abina S (2016) Gene therapy for X-linked severe combined immunodeficiency: where do we stand? Hum Gene Ther 27(2):108\u2013116. doi: 10.1089/hum.2015.137", "journal-title": "Hum Gene Ther"}, {"issue": "8", "key": "3_CR20", "doi-asserted-by": "publisher", "first-page": "1269", "DOI": "10.1007/s00262-012-1202-z", "volume": "61", "author": "M Chmielewski", "year": "2012", "unstructured": "Chmielewski M, Abken H (2012) CAR T cells transform to trucks: chimeric antigen receptor-redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer. Cancer Immunol Immunother 61(8):1269\u20131277. doi: 10.1007/s00262-012-1202-z", "journal-title": "Cancer Immunol Immunother"}, {"issue": "1", "key": "3_CR21", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1111/imr.12125", "volume": "257", "author": "M Chmielewski", "year": "2014", "unstructured": "Chmielewski M, Hombach AA, Abken H (2014) Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma. Immunol Rev 257(1):83\u201390. doi: 10.1111/imr.12125", "journal-title": "Immunol Rev"}, {"issue": "5238", "key": "3_CR22", "doi-asserted-by": "crossref", "first-page": "908", "DOI": "10.1126/science.270.5238.908a", "volume": "270", "author": "J Cohen", "year": "1995", "unstructured": "Cohen J (1995) IL-12 deaths: explanation and a puzzle. Science 270(5238):908", "journal-title": "Science"}, {"issue": "1", "key": "3_CR23", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1089/jir.2015.0049", "volume": "36", "author": "CA Cohen", "year": "2016", "unstructured": "Cohen CA, Shea AA, Heffron CL, Schmelz EM, Roberts PC (2016) Interleukin-12 immunomodulation delays the onset of lethal peritoneal disease of ovarian cancer. J Interferon Cytokine Res 36(1):62\u201373. doi: 10.1089/jir.2015.0049", "journal-title": "J Interferon Cytokine Res"}, {"issue": "11", "key": "3_CR24", "first-page": "2531", "volume": "56", "author": "MP Colombo", "year": "1996", "unstructured": "Colombo MP, Vagliani M, Spreafico F, Parenza M, Chiodoni C, Melani C, Stoppacciaro A (1996) Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res 56(11):2531\u20132534", "journal-title": "Cancer Res"}, {"issue": "15", "key": "3_CR25", "doi-asserted-by": "publisher", "first-page": "1703", "DOI": "10.1200/JCO.2014.60.3449", "volume": "33", "author": "KJ Curran", "year": "2015", "unstructured": "Curran KJ, Brentjens RJ (2015) Chimeric antigen receptor T cells for cancer immunotherapy. J Clin Oncol 33(15):1703\u20131706. doi: 10.1200/JCO.2014.60.3449", "journal-title": "J Clin Oncol"}, {"issue": "36", "key": "3_CR26", "doi-asserted-by": "publisher", "first-page": "5896", "DOI": "10.1200/JCO.2007.15.6794", "volume": "26", "author": "AI Daud", "year": "2008", "unstructured": "Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R (2008) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26(36):5896\u20135903. doi: 10.1200/JCO.2007.15.6794", "journal-title": "J Clin Oncol"}, {"key": "3_CR27", "unstructured": "Daud A, Algazi AP, Ashworth MT, Fong L, Lewis J, Chan SE, Buljan M, Molina MA, Takamura KT, Diep TT, Heller R, Pierce RH (2014) Bhatia S systemic antitumor effect and clinical response in a phase 2 trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma. In: 2014 ASCO annual meeting, Chicago, IL, p abstr. 9025"}, {"issue": "16", "key": "3_CR28", "doi-asserted-by": "publisher", "first-page": "4677", "DOI": "10.1158/1078-0432.CCR-07-0776", "volume": "13", "author": "M Vecchio Del", "year": "2007", "unstructured": "Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13(16):4677\u20134685. doi: 10.1158/1078-0432.CCR-07-0776", "journal-title": "Clin Cancer Res"}, {"issue": "10", "key": "3_CR29", "doi-asserted-by": "publisher", "first-page": "2246", "DOI": "10.4161/hv.24702", "volume": "9", "author": "MC Diehl", "year": "2013", "unstructured": "Diehl MC, Lee JC, Daniels SE, Tebas P, Khan AS, Giffear M, Sardesai NY, Bagarazzi ML (2013) Tolerability of intramuscular and intradermal delivery by CELLECTRA(R) adaptive constant current electroporation device in healthy volunteers. Hum Vaccin Immunother 9(10):2246\u20132252. doi: 10.4161/hv.24702", "journal-title": "Hum Vaccin Immunother"}, {"issue": "17", "key": "3_CR30", "doi-asserted-by": "publisher", "first-page": "2152", "DOI": "10.1200/JCO.2012.46.6441", "volume": "31", "author": "ME Dudley", "year": "2013", "unstructured": "Dudley ME, Gross CA, Somerville RP, Hong Y, Schaub NP, Rosati SF, White DE, Nathan D, Restifo NP, Steinberg SM, Wunderlich JR, Kammula US, Sherry RM, Yang JC, Phan GQ, Hughes MS, Laurencot CM, Rosenberg SA (2013) Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma. J Clin Oncol 31(17):2152\u20132159. doi: 10.1200/JCO.2012.46.6441", "journal-title": "J Clin Oncol"}, {"issue": "12", "key": "3_CR31", "first-page": "4263", "volume": "94", "author": "K Dunussi-Joannopoulos", "year": "1999", "unstructured": "Dunussi-Joannopoulos K, Runyon K, Erickson J, Schaub RG, Hawley RG, Leonard JP (1999) Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity. Blood 94(12):4263\u20134273", "journal-title": "Blood"}, {"issue": "5", "key": "3_CR32", "doi-asserted-by": "publisher", "first-page": "807", "DOI": "10.1016/j.jaad.2006.06.038", "volume": "55", "author": "M Duvic", "year": "2006", "unstructured": "Duvic M, Sherman ML, Wood GS, Kuzel TM, Olsen E, Foss F, Laliberte RJ, Ryan JL, Zonno K, Rook AH (2006) A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides. J Am Acad Dermatol 55(5):807\u2013813. doi: 10.1016/j.jaad.2006.06.038", "journal-title": "J Am Acad Dermatol"}, {"issue": "34", "key": "3_CR33", "doi-asserted-by": "publisher", "first-page": "8835", "DOI": "10.1200/JCO.2005.02.1691", "volume": "23", "author": "CF Eisenbeis", "year": "2005", "unstructured": "Eisenbeis CF, Lesinski GB, Anghelina M, Parihar R, Valentino D, Liu J, Nadella P, Sundaram P, Young DC, Sznol M, Walker MJ, Carson WE (2005) Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12. J Clin Oncol 23(34):8835\u20138844. doi: 10.1200/JCO.2005.02.1691", "journal-title": "J Clin Oncol"}, {"issue": "7", "key": "3_CR34", "doi-asserted-by": "publisher", "first-page": "1869", "DOI": "10.18632/oncotarget.1853", "volume": "5", "author": "J Fallon", "year": "2014", "unstructured": "Fallon J, Tighe R, Kradjian G, Guzman W, Bernhardt A, Neuteboom B, Lan Y, Sabzevari H, Schlom J, Greiner JW (2014) The immunocytokine NHS-IL12 as a potential cancer therapeutic. Oncotarget 5(7):1869\u20131884. doi: 10.18632/oncotarget.1853", "journal-title": "Oncotarget"}, {"key": "3_CR35", "unstructured": "Felzmann T, Buchroithner J, Marosi C, Nowosielsky M, Oberndorfer S, Ruckser R, R\u00f6ssler K, Azizi A, von Campe G, Karin Bordihn K (2013) First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme. In: AACR 104th annual meeting, Washington, DC, p abstr. 4658"}, {"issue": "1\u20133", "key": "3_CR36", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1016/j.jconrel.2005.09.024", "volume": "109", "author": "JG Fewell", "year": "2005", "unstructured": "Fewell JG, Matar M, Slobodkin G, Han SO, Rice J, Hovanes B, Lewis DH, Anwer K (2005) Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer. J Control Release 109(1\u20133):288\u2013298. doi: 10.1016/j.jconrel.2005.09.024", "journal-title": "J Control Release"}, {"issue": "8", "key": "3_CR37", "doi-asserted-by": "publisher", "first-page": "718", "DOI": "10.1002/jgm.1356", "volume": "11", "author": "JG Fewell", "year": "2009", "unstructured": "Fewell JG, Matar MM, Rice JS, Brunhoeber E, Slobodkin G, Pence C, Worker M, Lewis DH, Anwer K (2009) Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally. J Gene Med 11(8):718\u2013728. doi: 10.1002/jgm.1356", "journal-title": "J Gene Med"}, {"key": "3_CR38", "author": "JG Fewell", "year": "2016", "unstructured": "Fewell JG, Matar MM, Rice JK, McClure D, Brunhoeber E, Sparks J, Greenleaf S, Smith K, Anwer K (2016) Interleukin-12 gene therapy in combination with bevacizumab and pegylated liposomal doxorubicin for treatment of disseminated ovarian cancer. Paper presented at the AACR annual meeting, New Orleans, LA", "volume-title": "Interleukin-12 gene therapy in combination with bevacizumab and pegylated liposomal doxorubicin for treatment of disseminated ovarian cancer"}, {"issue": "9", "key": "3_CR39", "doi-asserted-by": "publisher", "first-page": "1971", "DOI": "10.1002/ijc.27755", "volume": "132", "author": "MF Fransen", "year": "2013", "unstructured": "Fransen MF, Arens R, Melief CJ (2013) Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment. Int J Cancer 132(9):1971\u20131976. doi: 10.1002/ijc.27755", "journal-title": "Int J Cancer"}, {"issue": "51", "key": "3_CR40", "doi-asserted-by": "publisher", "first-page": "7393", "DOI": "10.1016/j.vaccine.2015.08.096", "volume": "33", "author": "AB Frey", "year": "2015", "unstructured": "Frey AB (2015) Suppression of T cell responses in the tumor microenvironment. Vaccine 33(51):7393\u20137400. doi: 10.1016/j.vaccine.2015.08.096", "journal-title": "Vaccine"}, {"issue": "12", "key": "3_CR41", "doi-asserted-by": "publisher", "first-page": "1131", "DOI": "10.1038/gt.2013.40", "volume": "20", "author": "SO Freytag", "year": "2013", "unstructured": "Freytag SO, Barton KN, Zhang Y (2013) Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer. Gene Ther 20(12):1131\u20131139. doi: 10.1038/gt.2013.40", "journal-title": "Gene Ther"}, {"issue": "2", "key": "3_CR42", "doi-asserted-by": "publisher", "first-page": "268", "DOI": "10.1016/j.ijrobp.2014.02.034", "volume": "89", "author": "SO Freytag", "year": "2014", "unstructured": "Freytag SO, Stricker H, Lu M, Elshaikh M, Aref I, Pradhan D, Levin K, Kim JH, Peabody J, Siddiqui F, Barton K, Pegg J, Zhang Y, Cheng J, Oja-Tebbe N, Bourgeois R, Gupta N, Lane Z, Rodriguez R, DeWeese T, Movsas B (2014) Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 89(2):268\u2013276. doi: 10.1016/j.ijrobp.2014.02.034", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "4", "key": "3_CR43", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1038/nri3175", "volume": "12", "author": "DI Gabrilovich", "year": "2012", "unstructured": "Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253\u2013268. doi: 10.1038/nri3175", "journal-title": "Nat Rev Immunol"}, {"issue": "3 Suppl", "key": "3_CR44", "first-page": "895s", "volume": "7", "author": "TF Gajewski", "year": "2001", "unstructured": "Gajewski TF, Fallarino F, Ashikari A, Sherman M (2001) Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12. Clin Cancer Res 7(3 Suppl):895s\u2013901s", "journal-title": "Clin Cancer Res"}, {"key": "3_CR45", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1186/1756-8722-7-31", "volume": "7", "author": "Z Gluzman-Poltorak", "year": "2014", "unstructured": "Gluzman-Poltorak Z, Mendonca SR, Vainstein V, Kha H, Basile LA (2014) Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation. J Hematol Oncol 7:31. doi: 10.1186/1756-8722-7-31", "journal-title": "J Hematol Oncol"}, {"issue": "1", "key": "3_CR46", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1186/2162-3619-3-11", "volume": "3", "author": "MS Gokhale", "year": "2014", "unstructured": "Gokhale MS, Vainstein V, Tom J, Thomas S, Lawrence CE, Gluzman-Poltorak Z, Siebers N, Basile LA (2014) Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects. Exp Hematol Oncol 3(1):11. doi: 10.1186/2162-3619-3-11", "journal-title": "Exp Hematol Oncol"}, {"issue": "5", "key": "3_CR47", "first-page": "1678", "volume": "6", "author": "JA Gollob", "year": "2000", "unstructured": "Gollob JA, Mier JW, Veenstra K, McDermott DF, Clancy D, Clancy M, Atkins MB (2000) Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response. Clin Cancer Res 6(5):1678\u20131692", "journal-title": "Clin Cancer Res"}, {"issue": "13", "key": "3_CR48", "doi-asserted-by": "publisher", "first-page": "2564", "DOI": "10.1200/JCO.2003.12.119", "volume": "21", "author": "JA Gollob", "year": "2003", "unstructured": "Gollob JA, Veenstra KG, Parker RA, Mier JW, McDermott DF, Clancy D, Tutin L, Koon H, Atkins MB (2003) Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma. J Clin Oncol 21(13):2564\u20132573. doi: 10.1200/JCO.2003.12.119", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "3_CR49", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1007/s40265-015-0522-7", "volume": "76", "author": "SL Greig", "year": "2016", "unstructured": "Greig SL (2016) Talimogene laherparepvec: first global approval. Drugs 76(1):147\u2013154. doi: 10.1007/s40265-015-0522-7", "journal-title": "Drugs"}, {"issue": "16", "key": "3_CR50", "doi-asserted-by": "publisher", "first-page": "1509", "DOI": "10.1056/NEJMoa1215134", "volume": "368", "author": "SA Grupp", "year": "2013", "unstructured": "Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH (2013) Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 368(16):1509\u20131518. doi: 10.1056/NEJMoa1215134", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "3_CR51", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1046/j.1365-2249.2000.01112.x", "volume": "119", "author": "N Haicheur", "year": "2000", "unstructured": "Haicheur N, Escudier B, Dorval T, Negrier S, De Mulder PH, Dupuy JM, Novick D, Guillot T, Wolf S, Pouillart P, Fridman WH, Tartour E (2000) Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clin Exp Immunol 119(1):28\u201337", "journal-title": "Clin Exp Immunol"}, {"issue": "1", "key": "3_CR52", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1158/1078-0432.CCR-06-1450", "volume": "13", "author": "O Hamid", "year": "2007", "unstructured": "Hamid O, Solomon JC, Scotland R, Garcia M, Sian S, Ye W, Groshen SL, Weber JS (2007) Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk disease. Clin Cancer Res 13(1):215\u2013222. doi: 10.1158/1078-0432.CCR-06-1450", "journal-title": "Clin Cancer Res"}, {"issue": "5", "key": "3_CR53", "doi-asserted-by": "publisher", "first-page": "1503", "DOI": "10.1158/1078-0432.CCR-06-1603", "volume": "13", "author": "L Hansson", "year": "2007", "unstructured": "Hansson L, Abdalla AO, Moshfegh A, Choudhury A, Rabbani H, Nilsson B, Osterborg A, Mellstedt H (2007) Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients. Clin Cancer Res 13(5):1503\u20131510. doi: 10.1158/1078-0432.CCR-06-1603", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "3_CR54", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1089/hum.2005.16.35", "volume": "16", "author": "L Heinzerling", "year": "2005", "unstructured": "Heinzerling L, Burg G, Dummer R, Maier T, Oberholzer PA, Schultz J, Elzaouk L, Pavlovic J, Moelling K (2005) Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther 16(1):35\u201348. doi: 10.1089/hum.2005.16.35", "journal-title": "Hum Gene Ther"}, {"issue": "1", "key": "3_CR55", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1111/j.1365-2249.2006.03029.x", "volume": "144", "author": "S Homma", "year": "2006", "unstructured": "Homma S, Sagawa Y, Ito M, Ohno T, Toda G (2006) Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses. Clin Exp Immunol 144(1):41\u201347. doi: 10.1111/j.1365-2249.2006.03029.x", "journal-title": "Clin Exp Immunol"}, {"issue": "9", "key": "3_CR56", "doi-asserted-by": "crossref", "first-page": "576", "DOI": "10.1093/jnci/88.9.576", "volume": "88", "author": "S Jenks", "year": "1996", "unstructured": "Jenks S (1996) After initial setback, IL-12 regaining popularity. J Natl Cancer Inst 88(9):576\u2013577", "journal-title": "J Natl Cancer Inst"}, {"issue": "5", "key": "3_CR57", "doi-asserted-by": "publisher", "first-page": "818", "DOI": "10.1093/infdis/jit236", "volume": "208", "author": "SA Kalams", "year": "2013", "unstructured": "Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, Fuchs J, Koblin B, Kim DH, Joseph P, Keefer MC, Baden LR, Eldridge J, Boyer J, Sherwat A, Cardinali M, Allen M, Pensiero M, Butler C, Khan AS, Yan J, Sardesai NY, Kublin JG, Weiner DB, Network NHVT (2013) Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J Infect Dis 208(5):818\u2013829. doi: 10.1093/infdis/jit236", "journal-title": "J Infect Dis"}, {"issue": "9", "key": "3_CR58", "doi-asserted-by": "publisher", "first-page": "642", "DOI": "10.1038/nrd4663", "volume": "14", "author": "HL Kaufman", "year": "2015", "unstructured": "Kaufman HL, Kohlhapp FJ, Zloza A (2015) Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov 14(9):642\u2013662. doi: 10.1038/nrd4663", "journal-title": "Nat Rev Drug Discov"}, {"issue": "7", "key": "3_CR59", "doi-asserted-by": "publisher", "first-page": "1369", "DOI": "10.1038/mt.2013.58", "volume": "21", "author": "SP Kerkar", "year": "2013", "unstructured": "Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, Pan JH, Palmer DC, Morgan RA, Rosenberg SA, Restifo NP (2013) Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Mol Ther 21(7):1369\u20131377. doi: 10.1038/mt.2013.58", "journal-title": "Mol Ther"}, {"issue": "7", "key": "3_CR60", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1007/s002620100205", "volume": "50", "author": "T Kikuchi", "year": "2001", "unstructured": "Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T, Ohno T (2001) Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50(7):337\u2013344", "journal-title": "Cancer Immunol Immunother"}, {"issue": "6", "key": "3_CR61", "doi-asserted-by": "crossref", "first-page": "452", "DOI": "10.1097/00002371-200411000-00005", "volume": "27", "author": "T Kikuchi", "year": "2004", "unstructured": "Kikuchi T, Akasaki Y, Abe T, Fukuda T, Saotome H, Ryan JL, Kufe DW, Ohno T (2004) Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12. J Immunother 27(6):452\u2013459", "journal-title": "J Immunother"}, {"issue": "4", "key": "3_CR62", "doi-asserted-by": "publisher", "first-page": "798", "DOI": "10.1172/JCI24826", "volume": "115", "author": "EJ Kim", "year": "2005", "unstructured": "Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M, Rook AH (2005) Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 115(4):798\u2013812. doi: 10.1172/JCI24826", "journal-title": "J Clin Invest"}, {"key": "3_CR63", "doi-asserted-by": "publisher", "first-page": "102", "DOI": "10.1186/s12967-015-0460-x", "volume": "13", "author": "M Koneru", "year": "2015", "unstructured": "Koneru M, O\u2019Cearbhaill R, Pendharkar S, Spriggs DR, Brentjens RJ (2015) A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer. J Transl Med 13:102. doi: 10.1186/s12967-015-0460-x", "journal-title": "J Transl Med"}, {"issue": "5", "key": "3_CR64", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1016/0167-5699(96)30011-X", "volume": "17", "author": "AG Lamont", "year": "1996", "unstructured": "Lamont AG, Adorini L (1996) IL-12: a key cytokine in immune regulation. Immunol Today 17(5):214\u2013217", "journal-title": "Immunol Today"}, {"issue": "5", "key": "3_CR65", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1007/s00262-014-1523-1", "volume": "63", "author": "W Lasek", "year": "2014", "unstructured": "Lasek W, Zagozdzon R, Jakobisiak M (2014) Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother 63(5):419\u2013435. doi: 10.1007/s00262-014-1523-1", "journal-title": "Cancer Immunol Immunother"}, {"key": "3_CR66", "author": "FM Lebel", "year": "2016", "unstructured": "Lebel FM, Berrett JA, Chiocca A, Yu J, Vincas Lukas R, Nagpal S, Kumthekar P, Krishnan S, Cooper LJN (2016) Effect of controlled intratumoral viral delivery of Ad-RTS-hIL-12\u00a0+ oral veledimex in subjects with recurrent or progressive glioma. Paper presented at the ASCO annual meeting, Chicago, IL", "volume-title": "Effect of controlled intratumoral viral delivery of Ad-RTS-hIL-12+ oral veledimex in subjects with recurrent or progressive glioma"}, {"issue": "18", "key": "3_CR67", "doi-asserted-by": "crossref", "first-page": "3836", "DOI": "10.1200/JCO.2001.19.18.3836", "volume": "19", "author": "P Lee", "year": "2001", "unstructured": "Lee P, Wang F, Kuniyoshi J, Rubio V, Stuges T, Groshen S, Gee C, Lau R, Jeffery G, Margolin K, Marty V, Weber J (2001) Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma. J Clin Oncol 19(18):3836\u20133847", "journal-title": "J Clin Oncol"}, {"issue": "12", "key": "3_CR68", "first-page": "3686", "volume": "8", "author": "R Lenzi", "year": "2002", "unstructured": "Lenzi R, Rosenblum M, Verschraegen C, Kudelka AP, Kavanagh JJ, Hicks ME, Lang EA, Nash MA, Levy LB, Garcia ME, Platsoucas CD, Abbruzzese JL, Freedman RS (2002) Phase I study of intraperitoneal recombinant human interleukin 12 in patients with mullerian carcinoma, gastrointestinal primary malignancies, and mesothelioma. Clin Cancer Res 8(12):3686\u20133695", "journal-title": "Clin Cancer Res"}, {"key": "3_CR69", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1186/1479-5876-5-66", "volume": "5", "author": "R Lenzi", "year": "2007", "unstructured": "Lenzi R, Edwards R, June C, Seiden MV, Garcia ME, Rosenblum M, Freedman RS (2007) Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease <1\u00a0cm) associated with ovarian cancer or primary peritoneal carcinoma. J Transl Med 5:66. doi: 10.1186/1479-5876-5-66", "journal-title": "J Transl Med"}, {"issue": "7", "key": "3_CR70", "first-page": "2541", "volume": "90", "author": "JP Leonard", "year": "1997", "unstructured": "Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, Sosman JA, Dutcher JP, Vogelzang NJ, Ryan JL (1997) Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90(7):2541\u20132548", "journal-title": "Blood"}, {"key": "3_CR71", "unstructured": "Linette GP, Hamid O, Whitman ED, Nemunaitis JJ, Chesney J, Agarwala SS, Starodub A, John A Barrett JA, Marsh A, Martell LA, Cho A, Reed TD, Youssoufian H, Vergara-Silva A (2013) A phase I open-label study of Ad-RTS-hIL-12, an adenoviral vector engineered to express hIL-12 under the control of an oral activator ligand, in subjects with unresectable stage III/IV melanoma. In: 2013 ASCO annual meeting, Chicago, IL, p abstr. 3022"}, {"issue": "6", "key": "3_CR72", "doi-asserted-by": "publisher", "first-page": "e218", "DOI": "10.1016/S1470-2045(12)70582-X", "volume": "14", "author": "BE Lippitz", "year": "2013", "unstructured": "Lippitz BE (2013) Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol 14(6):e218\u2013e228. doi: 10.1016/S1470-2045(12)70582-X", "journal-title": "Lancet Oncol"}, {"issue": "12", "key": "3_CR73", "doi-asserted-by": "publisher", "first-page": "4653", "DOI": "10.1182/blood-2002-11-3589", "volume": "101", "author": "RF Little", "year": "2003", "unstructured": "Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H, Franchini G, Gutierrez M, Raffeld M, Jaffe ES, Shearer G, Yarchoan R, Wilson WH (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101(12):4653\u20134659. doi: 10.1182/blood-2002-11-3589", "journal-title": "Blood"}, {"issue": "12", "key": "3_CR74", "doi-asserted-by": "publisher", "first-page": "4650", "DOI": "10.1182/blood-2005-11-4455", "volume": "107", "author": "RF Little", "year": "2006", "unstructured": "Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Yarchoan R (2006) Activity of subcutaneous interleukin-12 in AIDS-related kaposi sarcoma. Blood 107(12):4650\u20134657. doi: 10.1182/blood-2005-11-4455", "journal-title": "Blood"}, {"issue": "13", "key": "3_CR75", "doi-asserted-by": "publisher", "first-page": "4165", "DOI": "10.1182/blood-2007-06-097568", "volume": "110", "author": "RF Little", "year": "2007", "unstructured": "Little RF, Aleman K, Kumar P, Wyvill KM, Pluda JM, Read-Connole E, Wang V, Pittaluga S, Catanzaro AT, Steinberg SM, Yarchoan R (2007) Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. Blood 110(13):4165\u20134171. doi: 10.1182/blood-2007-06-097568", "journal-title": "Blood"}, {"issue": "6", "key": "3_CR76", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1016/j.blre.2012.09.004", "volume": "26", "author": "MA Lunning", "year": "2012", "unstructured": "Lunning MA, Vose JM (2012) Management of indolent lymphoma: where are we now and where are we going. Blood Rev 26(6):279\u2013288. doi: 10.1016/j.blre.2012.09.004", "journal-title": "Blood Rev"}, {"issue": "8", "key": "3_CR77", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1038/sj.cgt.7701064", "volume": "14", "author": "DM Mahvi", "year": "2007", "unstructured": "Mahvi DM, Henry MB, Albertini MR, Weber S, Meredith K, Schalch H, Rakhmilevich A, Hank J, Sondel P (2007) Intratumoral injection of IL-12 plasmid DNA\u2013results of a phase I/IB clinical trial. Cancer Gene Ther 14(8):717\u2013723. doi: 10.1038/sj.cgt.7701064", "journal-title": "Cancer Gene Ther"}, {"issue": "10", "key": "3_CR78", "doi-asserted-by": "publisher", "first-page": "2329", "DOI": "10.1158/1078-0432.CCR-16-0224", "volume": "22", "author": "M Mandai", "year": "2016", "unstructured": "Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I (2016) Dual faces of IFNgamma in cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity. Clin Cancer Res 22(10):2329\u20132334. doi: 10.1158/1078-0432.CCR-16-0224", "journal-title": "Clin Cancer Res"}, {"issue": "12", "key": "3_CR79", "doi-asserted-by": "crossref", "first-page": "1737", "DOI": "10.1097/01.aids.0000131385.60974.b9", "volume": "18", "author": "L Martin-Carbonero", "year": "2004", "unstructured": "Martin-Carbonero L, Barrios A, Saballs P, Sirera G, Santos J, Palacios R, Valencia ME, Alegre M, Podzamczer D, Gonzalez-Lahoz J, Caelyx KSSG (2004) Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi\u2019s sarcoma. AIDS 18(12):1737\u20131740", "journal-title": "AIDS"}, {"issue": "26", "key": "3_CR80", "doi-asserted-by": "publisher", "first-page": "4017", "DOI": "10.1182/blood-2014-12-580068", "volume": "125", "author": "SL Maude", "year": "2015", "unstructured": "Maude SL, Teachey DT, Porter DL, Grupp SA (2015) CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood 125(26):4017\u20134023. doi: 10.1182/blood-2014-12-580068", "journal-title": "Blood"}, {"issue": "5", "key": "3_CR81", "first-page": "1183", "volume": "4", "author": "RJ Motzer", "year": "1998", "unstructured": "Motzer RJ, Rakhit A, Schwartz LH, Olencki T, Malone TM, Sandstrom K, Nadeau R, Parmar H, Bukowski R (1998) Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Clin Cancer Res 4(5):1183\u20131191", "journal-title": "Clin Cancer Res"}, {"issue": "4", "key": "3_CR82", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1089/107999001750169934", "volume": "21", "author": "RJ Motzer", "year": "2001", "unstructured": "Motzer RJ, Rakhit A, Thompson JA, Nemunaitis J, Murphy BA, Ellerhorst J, Schwartz LH, Berg WJ, Bukowski RM (2001) Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma. J Interferon Cytokine Res 21(4):257\u2013263. doi: 10.1089/107999001750169934", "journal-title": "J Interferon Cytokine Res"}, {"key": "3_CR83", "unstructured": "Nemunaitis JJ, Linette GP, Haythem A, Lebel F, Barrett JA, Reed T, Krishnan S, Lewis J (2014) Ad-RTS-hIL-12+ veledimex regulation of IL-12 expression in advanced breast cancer (BC) and melanoma patients. In: Tumor immunology and immunotherapy: a new chapter, Orlando, FL, p abstr. B11"}, {"issue": "6", "key": "3_CR84", "doi-asserted-by": "publisher", "first-page": "e0129954", "DOI": "10.1371/journal.pone.0129954", "volume": "10", "author": "M Paoloni", "year": "2015", "unstructured": "Paoloni M, Mazcko C, Selting K, Lana S, Barber L, Phillips J, Skorupski K, Vail D, Wilson H, Biller B, Avery A, Kiupel M, LeBlanc A, Bernhardt A, Brunkhorst B, Tighe R, Khanna C (2015) Defining the pharmacodynamic profile and therapeutic index of NHS-IL12 immunocytokine in dogs with malignant melanoma. PLoS ONE 10(6):e0129954. doi: 10.1371/journal.pone.0129954", "journal-title": "PLoS ONE"}, {"issue": "15", "key": "3_CR85", "doi-asserted-by": "publisher", "first-page": "5027", "DOI": "10.1158/1078-0432.CCR-04-0265", "volume": "10", "author": "R Parihar", "year": "2004", "unstructured": "Parihar R, Nadella P, Lewis A, Jensen R, De Hoff C, Dierksheide JE, VanBuskirk AM, Magro CM, Young DC, Shapiro CL, Carson WE 3rd (2004) A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res 10(15):5027\u20135037. doi: 10.1158/1078-0432.CCR-04-0265", "journal-title": "Clin Cancer Res"}, {"issue": "11\u201312", "key": "3_CR86", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1016/j.drudis.2012.01.007", "volume": "17", "author": "N Pasche", "year": "2012", "unstructured": "Pasche N, Neri D (2012) Immunocytokines: a novel class of potent armed antibodies. Drug Discov Today 17(11\u201312):583\u2013590. doi: 10.1016/j.drudis.2012.01.007", "journal-title": "Drug Discov Today"}, {"issue": "12", "key": "3_CR87", "doi-asserted-by": "publisher", "first-page": "2342", "DOI": "10.1200/JCO.2003.12.144", "volume": "21", "author": "AC Peterson", "year": "2003", "unstructured": "Peterson AC, Harlin H, Gajewski TF (2003) Immunization with melan-a peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J Clin Oncol 21(12):2342\u20132348. doi: 10.1200/JCO.2003.12.144", "journal-title": "J Clin Oncol"}, {"issue": "8", "key": "3_CR88", "doi-asserted-by": "publisher", "first-page": "725", "DOI": "10.1056/NEJMoa1103849", "volume": "365", "author": "DL Porter", "year": "2011", "unstructured": "Porter DL, Levine BL, Kalos M, Bagg A, June CH (2011) Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 365(8):725\u2013733. doi: 10.1056/NEJMoa1103849", "journal-title": "N Engl J Med"}, {"issue": "12", "key": "3_CR89", "first-page": "3983", "volume": "5", "author": "JE Portielje", "year": "1999", "unstructured": "Portielje JE, Kruit WH, Schuler M, Beck J, Lamers CH, Stoter G, Huber C, de Boer-Dennert M, Rakhit A, Bolhuis RL, Aulitzky WE (1999) Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer. Clin Cancer Res 5(12):3983\u20133989", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "3_CR90", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1007/s00262-002-0356-5", "volume": "52", "author": "JE Portielje", "year": "2003", "unstructured": "Portielje JE, Gratama JW, van Ojik HH, Stoter G, Kruit WH (2003a) IL-12: a promising adjuvant for cancer vaccination. Cancer Immunol Immunother 52(3):133\u2013144. doi: 10.1007/s00262-002-0356-5", "journal-title": "Cancer Immunol Immunother"}, {"issue": "1", "key": "3_CR91", "first-page": "76", "volume": "9", "author": "JE Portielje", "year": "2003", "unstructured": "Portielje JE, Lamers CH, Kruit WH, Sparreboom A, Bolhuis RL, Stoter G, Huber C, Gratama JW (2003b) Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. Clin Cancer Res 9(1):76\u201383", "journal-title": "Clin Cancer Res"}, {"issue": "4", "key": "3_CR92", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1038/nri3191", "volume": "12", "author": "NP Restifo", "year": "2012", "unstructured": "Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12(4):269\u2013281. doi: 10.1038/nri3191", "journal-title": "Nat Rev Immunol"}, {"issue": "1", "key": "3_CR93", "first-page": "9", "volume": "5", "author": "MJ Robertson", "year": "1999", "unstructured": "Robertson MJ, Cameron C, Atkins MB, Gordon MS, Lotze MT, Sherman ML, Ritz J (1999) Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clin Cancer Res 5(1):9\u201316", "journal-title": "Clin Cancer Res"}, {"issue": "11", "key": "3_CR94", "first-page": "3383", "volume": "8", "author": "MJ Robertson", "year": "2002", "unstructured": "Robertson MJ, Pelloso D, Abonour R, Hromas RA, Nelson RP Jr, Wood L, Cornetta K (2002) Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies. Clin Cancer Res 8(11):3383\u20133393", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "3_CR95", "first-page": "1491", "volume": "154", "author": "AH Rook", "year": "1995", "unstructured": "Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR (1995) IL-12 reverses cytokine and immune abnormalities in sezary syndrome. J Immunol 154(3):1491\u20131498", "journal-title": "J Immunol"}, {"issue": "3", "key": "3_CR96", "first-page": "902", "volume": "94", "author": "AH Rook", "year": "1999", "unstructured": "Rook AH, Wood GS, Yoo EK, Elenitsas R, Kao DM, Sherman ML, Witmer WK, Rockwell KA, Shane RB, Lessin SR, Vonderheid EC (1999) Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood 94(3):902\u2013908", "journal-title": "Blood"}, {"issue": "4", "key": "3_CR97", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1038/nrc2355", "volume": "8", "author": "SA Rosenberg", "year": "2008", "unstructured": "Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8(4):299\u2013308. doi: 10.1038/nrc2355", "journal-title": "Nat Rev Cancer"}, {"issue": "13", "key": "3_CR98", "doi-asserted-by": "publisher", "first-page": "4550", "DOI": "10.1158/1078-0432.CCR-11-0116", "volume": "17", "author": "SA Rosenberg", "year": "2011", "unstructured": "Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME (2011) Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 17(13):4550\u20134557. doi: 10.1158/1078-0432.CCR-11-0116", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "3_CR99", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1182/blood-2010-04-277137", "volume": "117", "author": "J Rosenblatt", "year": "2011", "unstructured": "Rosenblatt J, Vasir B, Uhl L, Blotta S, Macnamara C, Somaiya P, Wu Z, Joyce R, Levine JD, Dombagoda D, Yuan YE, Francoeur K, Fitzgerald D, Richardson P, Weller E, Anderson K, Kufe D, Munshi N, Avigan D (2011) Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma. Blood 117(2):393\u2013402. doi: 10.1182/blood-2010-04-277137", "journal-title": "Blood"}, {"issue": "13", "key": "3_CR100", "doi-asserted-by": "publisher", "first-page": "3640", "DOI": "10.1158/1078-0432.CCR-13-0282", "volume": "19", "author": "J Rosenblatt", "year": "2013", "unstructured": "Rosenblatt J, Avivi I, Vasir B, Uhl L, Munshi NC, Katz T, Dey BR, Somaiya P, Mills H, Campigotto F, Weller E, Joyce R, Levine JD, Tzachanis D, Richardson P, Laubach J, Raje N, Boussiotis V, Yuan YE, Bisharat L, Held V, Rowe J, Anderson K, Kufe D, Avigan D (2013) Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients. Clin Cancer Res 19(13):3640\u20133648. doi: 10.1158/1078-0432.CCR-13-0282", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "3_CR101", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1089/humc.2013.201", "volume": "25", "author": "JC Roth", "year": "2014", "unstructured": "Roth JC, Cassady KA, Cody JJ, Parker JN, Price KH, Coleman JM, Peggins JO, Noker PE, Powers NW, Grimes SD, Carroll SL, Gillespie GY, Whitley RJ, Markert JM (2014) Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates. Hum Gene Ther Clin Dev 25(1):16\u201327. doi: 10.1089/humc.2013.201", "journal-title": "Hum Gene Ther Clin Dev"}, {"issue": "7", "key": "3_CR102", "doi-asserted-by": "publisher", "first-page": "1998", "DOI": "10.1158/1078-0432.CCR-10-2490", "volume": "17", "author": "SM Rudman", "year": "2011", "unstructured": "Rudman SM, Jameson MB, McKeage MJ, Savage P, Jodrell DI, Harries M, Acton G, Erlandsson F, Spicer JF (2011) A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinoma. Clin Cancer Res 17(7):1998\u20132005. doi: 10.1158/1078-0432.CCR-10-2490", "journal-title": "Clin Cancer Res"}, {"key": "3_CR103", "unstructured": "Schwartzentruber DJ, Kirkwood JM, Guarino MJ, Richards JM, Hamid O, O\u2019Day S, Nemunaitis JJ, Talmadge JE, Chada S, Menander KB, Shafer-Weaver K, Senesac JH, Thornton MO, Lewis JJ, Herberma RB (2011) Immunotherapy of advanced melanoma by intratumoral injections of autologous, purified dendritic cells transduced with gene construct of interleukin-12, with dose-dependent expression under the control of an oral activator ligand. In: 2011 ASCO annual meeting, J Clin Oncol, p abstr. 2540", "DOI": "10.1200/jco.2011.29.15_suppl.2540", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "3_CR104", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1007/s40265-014-0339-9", "volume": "75", "author": "LJ Scott", "year": "2015", "unstructured": "Scott LJ (2015) Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency. Drugs 75(2):175\u2013182. doi: 10.1007/s40265-014-0339-9", "journal-title": "Drugs"}, {"issue": "5", "key": "3_CR105", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.1038/gt.2010.170", "volume": "18", "author": "SH Seo", "year": "2011", "unstructured": "Seo SH, Kim KS, Park SH, Suh YS, Kim SJ, Jeun SS, Sung YC (2011) The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity. Gene Ther 18(5):488\u2013495. doi: 10.1038/gt.2010.170", "journal-title": "Gene Ther"}, {"key": "3_CR106", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1016/j.addr.2015.10.014", "volume": "98", "author": "PY Teo", "year": "2016", "unstructured": "Teo PY, Cheng W, Hedrick JL, Yang YY (2016) Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug Deliv Rev 98:41\u201363. doi: 10.1016/j.addr.2015.10.014", "journal-title": "Adv Drug Deliv Rev"}, {"key": "3_CR107", "unstructured": "Thaker PH, Brady WE, Bradley WH, Anwer K, Alvarez RD (2015) Phase I study of intraperitoneal IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer administered in combination with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, Fallopian tube, or primary peritoneal cancer patients: an NRG/GOG study. In: 2015 ASCO annual meeting, J Clin Oncol, p abstr. 5541"}, {"key": "3_CR108", "doi-asserted-by": "publisher", "first-page": "e505", "DOI": "10.14694/EDBK_159087", "volume": "35", "author": "AC Akkooi van", "year": "2016", "unstructured": "van Akkooi AC, Atkins MB, Agarwala SS, Lorigan P (2016) Surgical management and adjuvant therapy for high-risk and metastatic melanoma. Am Soc Clin Oncol Educ Book 35:e505\u2013e514. doi: 10.14694/EDBK_159087", "journal-title": "Am Soc Clin Oncol Educ Book"}, {"key": "3_CR109", "unstructured": "Wadler S, Levy D, Frederickson HL, Falkson CI, Wang Y, Weller E, Burk R, Ho G, Kadish AS, Eastern Cooperative Oncology G (2004) A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. eastern cooperative oncology group study E1E96. Gynecol Oncol 92(3):957\u2013964. doi: 10.1016/j.ygyno.2003.12.022", "DOI": "10.1016/j.ygyno.2003.12.022", "doi-asserted-by": "publisher"}, {"issue": "11", "key": "3_CR110", "doi-asserted-by": "publisher", "first-page": "1705", "DOI": "10.1517/14712598.7.11.1705", "volume": "7", "author": "JM Weiss", "year": "2007", "unstructured": "Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH (2007) Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 7(11):1705\u20131721. doi: 10.1517/14712598.7.11.1705", "journal-title": "Expert Opin Biol Ther"}, {"key": "3_CR111", "unstructured": "Yang Z, Aggarval C, Cohen R, Morrow M, Bauml J, Weinstein G, Boyer J (2015) Immunotherapy with INO-3112 (HPV16 and HPV18 plasmids + IL-12 DNA) in human papillomaviruas (HPV)-associated head and neck squamous cell carcinoma (HNSCCa). In: ESMO symposium on immuno-oncology, Lausanne, Switzerland, Ann Oncol, p abstr. 1PD"}, {"issue": "8", "key": "3_CR112", "doi-asserted-by": "publisher", "first-page": "541", "DOI": "10.1038/nrg3763", "volume": "15", "author": "H Yin", "year": "2014", "unstructured": "Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15(8):541\u2013555. doi: 10.1038/nrg3763", "journal-title": "Nat Rev Genet"}, {"issue": "16", "key": "3_CR113", "doi-asserted-by": "publisher", "first-page": "5432", "DOI": "10.1158/1078-0432.CCR-04-0540", "volume": "10", "author": "A Younes", "year": "2004", "unstructured": "Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F (2004) Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-hodgkin\u2019s lymphoma and hodgkin\u2019s disease. Clin Cancer Res 10(16):5432\u20135438. doi: 10.1158/1078-0432.CCR-04-0540", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "3_CR114", "doi-asserted-by": "publisher", "first-page": "176", "DOI": "10.3109/08977194.2012.678843", "volume": "30", "author": "AE Yuzhalin", "year": "2012", "unstructured": "Yuzhalin AE, Kutikhin AG (2012) Interleukin-12: clinical usage and molecular markers of cancer susceptibility. Growth Factors 30(3):176\u2013191. doi: 10.3109/08977194.2012.678843", "journal-title": "Growth Factors"}, {"issue": "10", "key": "3_CR115", "doi-asserted-by": "publisher", "first-page": "2278", "DOI": "10.1158/1078-0432.CCR-14-2085", "volume": "21", "author": "L Zhang", "year": "2015", "unstructured": "Zhang L, Morgan RA, Beane JD, Zheng Z, Dudley ME, Kassim SH, Nahvi AV, Ngo LT, Sherry RM, Phan GQ, Hughes MS, Kammula US, Feldman SA, Toomey MA, Kerkar SP, Restifo NP, Yang JC, Rosenberg SA (2015) Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clin Cancer Res 21(10):2278\u20132288. doi: 10.1158/1078-0432.CCR-14-2085", "journal-title": "Clin Cancer Res"}], "container-title": ["Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology", "SpringerBriefs in Immunology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-46906-5_3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T23:32:35Z", "timestamp": 1498347155000}, "score": 30.073513, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319469058", "9783319469065"], "references-count": 115, "URL": "http://dx.doi.org/10.1007/978-3-319-46906-5_3", "relation": {"cites": []}, "ISSN": ["2194-2773", "2194-2781"], "issn-type": [{"value": "2194-2773", "type": "print"}, {"value": "2194-2781", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T09:12:56Z", "timestamp": 1525770776428}, "reference-count": 5, "publisher": "Springer Nature", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2014, 3, 12]], "date-time": "2014-03-12T00:00:00Z", "timestamp": 1394582400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.1186/bcr3624", "type": "journal-article", "created": {"date-parts": [[2014, 3, 12]], "date-time": "2014-03-12T12:13:30Z", "timestamp": 1394626410000}, "source": "Crossref", "is-referenced-by-count": 2, "title": ["\nIn silico analysis of microRNA-510 as a potential oncomir in human breast cancer"], "prefix": "10.1186", "volume": "16", "author": [{"given": "Pawel", "family": "Gaj", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 3, 12]]}, "reference": [{"key": "3379_CR1", "doi-asserted-by": "crossref", "first-page": "R70", "DOI": "10.1186/bcr3464", "volume": "15", "author": "QJ Guo", "year": "2013", "unstructured": "Guo QJ, Mills JN, Bandurraga SG, Nogueira LM, Mason NJ, Camp ER, Larue AC, Turner DP, Findlay VJ: MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer. Breast Cancer Res 2013, 15:R70.", "journal-title": "Breast Cancer Res"}, {"key": "3379_CR2", "doi-asserted-by": "crossref", "first-page": "8499", "DOI": "10.1158/0008-5472.CAN-08-0907", "volume": "68", "author": "VJ Findlay", "year": "2008", "unstructured": "Findlay VJ, Turner DP, Moussa O, Watson DK: MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res 2008, 68:8499\u20138506.", "journal-title": "Cancer Res"}, {"key": "3379_CR3", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1038/nature11412", "volume": "490", "author": "The Cancer Genome Atlas Network", "year": "2012", "unstructured": "The Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61\u201370.", "journal-title": "Nature"}, {"key": "3379_CR4", "doi-asserted-by": "crossref", "first-page": "4443", "DOI": "10.1158/0008-5472.CAN-11-0608", "volume": "71", "author": "TA Farazi", "year": "2011", "unstructured": "Farazi TA, Horlings HM, Ten HJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, Kreike B, Sie D, Hovestadt V, Wessels L, van de Vijver MJ, Tuschl T: MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 2011, 71:4443\u20134453.", "journal-title": "Cancer Res"}, {"key": "3379_CR5", "doi-asserted-by": "crossref", "first-page": "e16915", "DOI": "10.1371/journal.pone.0016915", "volume": "6", "author": "E Enerly", "year": "2011", "unstructured": "Enerly E, Steinfeld I, Kleivi K, Leivonen S-K, Aure MR, Russnes HG, R\u00f8nneberg JA, Johnsen H, Navon R, R\u00f8dland E, M\u00e4kel\u00e4 R, Naume B, Per\u00e4l\u00e4 M, Kallioniemi O, Kristensen VN, Yakhini Z, B\u00f8rresen-Dale A-L: miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 2011, 6:e16915.", "journal-title": "PLoS One"}], "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1186/bcr3624/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr3624.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr3624.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T08:06:45Z", "timestamp": 1497514005000}, "score": 30.073513, "issued": {"date-parts": [[2014, 3, 12]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2014, 4]]}, "issue": "2"}, "alternative-id": ["3379"], "URL": "http://dx.doi.org/10.1186/bcr3624", "relation": {"cites": []}, "ISSN": ["1465-5411", "1465-542X"], "issn-type": [{"value": "1465-5411", "type": "print"}, {"value": "1465-542X", "type": "electronic"}], "article-number": "3379"}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T05:46:13Z", "timestamp": 1525326373692}, "reference-count": 8, "publisher": "Oxford University Press (OUP)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1998, 2, 4]]}, "DOI": "10.1093/jnci/90.3.247", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T22:24:57Z", "timestamp": 1027722297000}, "page": "247-248", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Re: Greying of America Will Foster New Strategies in Oncology"], "prefix": "10.1093", "volume": "90", "author": [{"given": "Wojciech", "family": "Feleszko", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Marek", "family": "Jakobisiak", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[1998, 2, 4]]}, "reference": [{"key": "\nkey\n\t\t\t\t20170702093214_bib1", "first-page": "1398", "article-title": "Greying of America will foster new strategies in oncology", "volume": "89", "author": "McNeil", "year": "1997", "journal-title": "J Natl Cancer Inst"}, {"key": "\nkey\n\t\t\t\t20170702093214_bib2", "first-page": "1383", "article-title": "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)", "volume": "344", "author": "Scandinavian Simvastatin Survival Study Group", "year": "1996", "journal-title": "Lancet"}, {"key": "\nkey\n\t\t\t\t20170702093214_bib3", "doi-asserted-by": "crossref", "first-page": "3628", "DOI": "10.1073/pnas.88.9.3628", "article-title": "Cell cycle-specific effects of lovastatin", "volume": "88", "author": "Jakobisiak", "year": "1991", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "\nkey\n\t\t\t\t20170702093214_bib4", "doi-asserted-by": "crossref", "first-page": "1748", "DOI": "10.1172/JCI112165", "article-title": "Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase", "volume": "76", "author": "Maltese", "year": "1985", "journal-title": "J Clin Invest"}, {"key": "\nkey\n\t\t\t\t20170702093214_bib5", "author": "Feleszko", "year": "1998", "article-title": "Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice", "volume-title": "Eur J Cancer", "DOI": "10.1016/S0959-8049(97)10034-X", "doi-asserted-by": "crossref"}, {"key": "\nkey\n\t\t\t\t20170702093214_bib6", "first-page": "483", "article-title": "Phase I study of lovastatin, an inhibitor of the mevalonate pathway in patients with cancer", "volume": "2", "author": "Thibault", "year": "1996", "journal-title": "Clin Cancer Res"}, {"key": "\nkey\n\t\t\t\t20170702093214_bib7", "first-page": "4348", "article-title": "Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N,N\u2032-bis(2-chlorethyl)-N-nitrosourea and \u03b2-interferon on human glioma cells", "volume": "52", "author": "Soma", "year": "1992", "journal-title": "Cancer Res"}, {"key": "\nkey\n\t\t\t\t20170702093214_bib8", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1038/nm0396-326", "article-title": "HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells", "volume": "2", "author": "Dimitroulakos", "year": "1996", "journal-title": "Nat Med"}], "container-title": ["JNCI: Journal of the National Cancer Institute"], "language": "en", "link": [{"URL": "http://academic.oup.com/jnci/article-pdf/90/3/247/18048806/90-3-247.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 7]], "date-time": "2017-12-07T07:51:21Z", "timestamp": 1512633081000}, "score": 25.29527, "issued": {"date-parts": [[1998, 2, 4]]}, "references-count": 8, "journal-issue": {"published-online": {"date-parts": [[1998, 2, 4]]}, "published-print": {"date-parts": [[1998, 2, 4]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1093/jnci/90.3.247", "relation": {"cites": []}, "ISSN": ["0027-8874", "1460-2105"], "issn-type": [{"value": "0027-8874", "type": "print"}, {"value": "1460-2105", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T06:44:50Z", "timestamp": 1525416290313}, "publisher-location": "New Jersey", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "1592597831", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-783-1:397", "type": "book-chapter", "created": {"date-parts": [[2004, 8, 12]], "date-time": "2004-08-12T19:05:29Z", "timestamp": 1092337529000}, "page": "397-406", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Use of Antisense Oligonucleotide Technology to Investigate Signaling Pathways in Megakaryocytes"], "prefix": "10.1007", "author": [{"given": "Hava", "family": "Avraham", "sequence": "first", "affiliation": []}, {"given": "Shalom", "family": "Avraham", "sequence": "additional", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Platelets and Megakaryocytes"], "deposited": {"date-parts": [[2013, 1, 3]], "date-time": "2013-01-03T13:45:15Z", "timestamp": 1357220715000}, "score": 25.29527, "issued": {"date-parts": [[null]]}, "ISBN": ["1592597831"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-783-1:397"}, {"indexed": {"date-parts": [[2018, 12, 1]], "date-time": "2018-12-01T23:10:37Z", "timestamp": 1543705837645}, "reference-count": 62, "publisher": "Elsevier BV", "issue": "17-18", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 9, 1]], "date-time": "2011-09-01T00:00:00Z", "timestamp": 1314835200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today"], "published-print": {"date-parts": [[2011, 9]]}, "DOI": "10.1016/j.drudis.2011.06.003", "type": "journal-article", "created": {"date-parts": [[2011, 6, 26]], "date-time": "2011-06-26T01:13:35Z", "timestamp": 1309050815000}, "page": "810-816", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Truncated HER2: implications for HER2-targeted therapeutics"], "prefix": "10.1016", "volume": "16", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "William M.", "family": "Gallagher", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Crown", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359644611001814?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359644611001814?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 1]], "date-time": "2018-12-01T22:56:26Z", "timestamp": 1543704986000}, "score": 25.29527, "issued": {"date-parts": [[2011, 9]]}, "references-count": 62, "journal-issue": {"published-print": {"date-parts": [[2011, 9]]}, "issue": "17-18"}, "alternative-id": ["S1359644611001814"], "URL": "http://dx.doi.org/10.1016/j.drudis.2011.06.003", "ISSN": ["1359-6446"], "issn-type": [{"value": "1359-6446", "type": "print"}], "subject": ["Pharmacology", "Drug Discovery"]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T09:03:03Z", "timestamp": 1525770183414}, "reference-count": 0, "publisher": "Spandidos Publications", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int J Oncol"], "DOI": "10.3892/ijo.32.3.619", "type": "journal-article", "created": {"date-parts": [[2014, 3, 10]], "date-time": "2014-03-10T07:32:45Z", "timestamp": 1394436765000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma"], "prefix": "10.3892", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Yigong", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[2008, 3, 1]]}, "container-title": ["International Journal of Oncology"], "link": [{"URL": "https://spandidos-publications.com/10.3892/ijo.32.3.619/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T09:52:15Z", "timestamp": 1493286735000}, "score": 25.29527, "issued": {"date-parts": [[2008, 3, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3892/ijo.32.3.619", "ISSN": ["1019-6439", "1791-2423"], "issn-type": [{"value": "1019-6439", "type": "print"}, {"value": "1791-2423", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 10, 2]], "date-time": "2018-10-02T15:22:44Z", "timestamp": 1538493764652}, "reference-count": 63, "publisher": "Springer Nature", "issue": "4", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2018, 1, 17]], "date-time": "2018-01-17T00:00:00Z", "timestamp": 1516147200000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/100010661", "name": "Horizon 2020 Framework Programme", "doi-asserted-by": "publisher", "award": ["692180-STREAM-H2020-TWINN-2015"]}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Arch. Immunol. Ther. Exp."], "published-print": {"date-parts": [[2018, 8]]}, "DOI": "10.1007/s00005-018-0504-z", "type": "journal-article", "created": {"date-parts": [[2018, 1, 17]], "date-time": "2018-01-17T11:38:03Z", "timestamp": 1516189083000}, "page": "289-298", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Application of Genome Editing Techniques in Immunology"], "prefix": "10.1007", "volume": "66", "author": [{"given": "Agata O.", "family": "Zych", "sequence": "first", "affiliation": []}, {"given": "Malgorzata", "family": "Bajor", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0002-7957-2372", "authenticated-orcid": false, "given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 1, 17]]}, "reference": [{"key": "504_CR1", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/j.jmb.2007.04.079", "volume": "371", "author": "S Arnould", "year": "2007", "unstructured": "Arnould S, Perez C, Cabaniols JP et al (2007) Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells. J Mol Biol 371:49\u201365", "journal-title": "J Mol Biol"}, {"key": "504_CR2", "doi-asserted-by": "crossref", "first-page": "1709", "DOI": "10.1126/science.1138140", "volume": "315", "author": "R Barrangou", "year": "2007", "unstructured": "Barrangou R, Fremaux C, Deveau H et al (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709\u20131712", "journal-title": "Science"}, {"issue": "Pt 8", "key": "504_CR3", "first-page": "2551", "volume": "151", "author": "A Bolotin", "year": "2005", "unstructured": "Bolotin A, Quinquis B, Sorokin A et al (2005) Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151(Pt 8):2551\u20132561", "journal-title": "Microbiology"}, {"key": "504_CR4", "first-page": "5052369", "volume": "2016", "author": "S Chi", "year": "2016", "unstructured": "Chi S, Weiss A, Wang H (2016) A CRISPR-based toolbox for studying T cell signal transduction. Biomed Res Int 2016:5052369", "journal-title": "Biomed Res Int"}, {"key": "504_CR5", "doi-asserted-by": "crossref", "first-page": "24356", "DOI": "10.1038/srep24356", "volume": "6", "author": "TW Chiang", "year": "2016", "unstructured": "Chiang TW, le Sage C, Larrieu D et al (2016) CRISPR\u2013Cas9D10A nickase-based genotypic and phenotypic screening to enhance genome editing. Sci Rep 6:24356", "journal-title": "Sci Rep"}, {"key": "504_CR6", "doi-asserted-by": "crossref", "first-page": "757", "DOI": "10.1534/genetics.110.120717", "volume": "186", "author": "M Christian", "year": "2010", "unstructured": "Christian M, Cermak T, Doyle EL et al (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757\u2013761", "journal-title": "Genetics"}, {"key": "504_CR7", "doi-asserted-by": "crossref", "first-page": "12514", "DOI": "10.1073/pnas.1613884113", "volume": "113", "author": "VT Chu", "year": "2016", "unstructured": "Chu VT, Graf R, Wirtz T et al (2016) Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci USA 113:12514\u201312519", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "504_CR8", "doi-asserted-by": "crossref", "first-page": "819", "DOI": "10.1126/science.1231143", "volume": "339", "author": "L Cong", "year": "2013", "unstructured": "Cong L, Ran FA, Cox D et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819\u2013823", "journal-title": "Science"}, {"key": "504_CR9", "doi-asserted-by": "crossref", "first-page": "9584", "DOI": "10.1093/nar/gkt714", "volume": "41", "author": "TJ Cradick", "year": "2013", "unstructured": "Cradick TJ, Fine EJ, Antico CJ et al (2013) CRISPR/Cas9 systems targeting \u03b2-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res 41:9584\u20139592", "journal-title": "Nucleic Acids Res"}, {"key": "504_CR10", "doi-asserted-by": "crossref", "first-page": "16067", "DOI": "10.1038/mtm.2016.67", "volume": "3", "author": "DL DiGiusto", "year": "2016", "unstructured": "DiGiusto DL, Cannon PM, Holmes MC et al (2016) Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells. Mol Ther Methods Clin Dev 3:16067", "journal-title": "Mol Ther Methods Clin Dev"}, {"key": "504_CR11", "doi-asserted-by": "crossref", "first-page": "5233", "DOI": "10.1200/JCO.2008.16.5449", "volume": "26", "author": "ME Dudley", "year": "2008", "unstructured": "Dudley ME, Yang JC, Sherry R et al (2008) Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 26:5233\u20135239", "journal-title": "J Clin Oncol"}, {"key": "504_CR12", "doi-asserted-by": "crossref", "first-page": "5978", "DOI": "10.1093/nar/gki912", "volume": "33", "author": "S Durai", "year": "2005", "unstructured": "Durai S, Mani M, Kandavelou K et al (2005) Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucleic Acids Res 33:5978\u20135990", "journal-title": "Nucleic Acids Res"}, {"key": "504_CR13", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1038/nbt.2808", "volume": "32", "author": "Y Fu", "year": "2014", "unstructured": "Fu Y, Sander JD, Reyon D et al (2014) Improving CRISPR\u2013Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32:279\u2013284", "journal-title": "Nat Biotechnol"}, {"key": "504_CR14", "doi-asserted-by": "crossref", "first-page": "1049", "DOI": "10.3390/ph7121049", "volume": "7", "author": "H Fujiwara", "year": "2014", "unstructured": "Fujiwara H (2014) Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors. Pharmaceuticals 7:1049\u20131068", "journal-title": "Pharmaceuticals"}, {"key": "504_CR15", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1016/j.tibtech.2013.04.004", "volume": "31", "author": "T Gaj", "year": "2013", "unstructured": "Gaj T, Gersbach CA, Barbas CF (2013) ZFN, TALEN and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31:397\u2013405", "journal-title": "Trends Biotechnol"}, {"key": "504_CR16", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1038/nature09523", "volume": "468", "author": "JE Garneau", "year": "2010", "unstructured": "Garneau JE, Dupuis M, Villion M et al (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468:67\u201371", "journal-title": "Nature"}, {"key": "504_CR17", "doi-asserted-by": "crossref", "first-page": "5405", "DOI": "10.1093/nar/gkp548", "volume": "37", "author": "S Grizot", "year": "2009", "unstructured": "Grizot S, Smith J, Daboussi F et al (2009) Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease. Nucleic Acids Res 37:5405\u20135419", "journal-title": "Nucleic Acids Res"}, {"key": "504_CR18", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1016/j.csbj.2016.12.006", "volume": "15", "author": "TK Guha", "year": "2017", "unstructured": "Guha TK, Wai A, Hausner G (2017) Programmable genome editing tools and their regulation for efficient genome engineering. Comput Struct Biotechnol J 15:146\u2013160", "journal-title": "Comput Struct Biotechnol J"}, {"key": "504_CR19", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1016/j.celrep.2016.09.092", "volume": "17", "author": "MC Gundry", "year": "2016", "unstructured": "Gundry MC, Brunetti L, Lin A et al (2016) Highly efficient genome editing of murine and human hematopoietic progenitor cells by CRISPR/Cas9. Cell Rep 17:1453\u20131461", "journal-title": "Cell Rep"}, {"key": "504_CR20", "doi-asserted-by": "crossref", "first-page": "1570", "DOI": "10.1038/mt.2016.105", "volume": "24", "author": "KS Gwiazda", "year": "2016", "unstructured": "Gwiazda KS, Grier AE, Sahni J et al (2016) High efficiency CRISPR/Cas9-mediated gene editing in primary human T-cells using mutant adenoviral E4orf6/E1b55k \u201chelper\u201d proteins. Mol Ther 24:1570\u20131580", "journal-title": "Mol Ther"}, {"key": "504_CR21", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1182/blood-2006-03-013318", "volume": "109", "author": "MH Heemskerk", "year": "2007", "unstructured": "Heemskerk MH, Hagedoorn RS, Hoorn MA et al (2007) Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 109:235\u2013243", "journal-title": "Blood"}, {"key": "504_CR22", "doi-asserted-by": "crossref", "first-page": "985", "DOI": "10.1038/nbt.3290", "volume": "33", "author": "A Hendel", "year": "2015", "unstructured": "Hendel A, Bak RO, Clark JT et al (2015) Chemically modified guide RNAs enhance CRISPR\u2013Cas genome editing in human primary cells. Nat Biotechnol 33:985\u2013989", "journal-title": "Nat Biotechnol"}, {"key": "504_CR23", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1007/s00005-016-0427-5", "volume": "65", "author": "M Hryhorowicz", "year": "2017", "unstructured": "Hryhorowicz M, Lipi\u0144ski D, Zeyland J et al (2017) CRISPR/Cas9 immune system as a tool for genome engineering. Arch Immunol Ther Exp 65:233\u2013240", "journal-title": "Arch Immunol Ther Exp"}, {"key": "504_CR24", "doi-asserted-by": "crossref", "first-page": "5429", "DOI": "10.1128/jb.169.12.5429-5433.1987", "volume": "169", "author": "Y Ishino", "year": "1987", "unstructured": "Ishino Y, Shinagawa H, Makino K et al (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169:5429\u20135433", "journal-title": "J Bacteriol"}, {"key": "504_CR25", "doi-asserted-by": "crossref", "first-page": "5636", "DOI": "10.1158/1078-0432.CCR-13-0458", "volume": "19", "author": "LB John", "year": "2013", "unstructured": "John LB, Devaud C, Duong CP et al (2013) Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells. Clin Cancer Res 19:5636\u20135646", "journal-title": "Clin Cancer Res"}, {"key": "504_CR26", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1038/nrm3486", "volume": "14", "author": "JK Joung", "year": "2013", "unstructured": "Joung JK, Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14:49\u201355", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "504_CR27", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.4161/rna.24203", "volume": "10", "author": "T Karvelis", "year": "2013", "unstructured": "Karvelis T, Gasiunas G, Miksys A et al (2013) crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus. RNA Biol 10:841\u2013851", "journal-title": "RNA Biol"}, {"key": "504_CR28", "doi-asserted-by": "crossref", "first-page": "9779", "DOI": "10.1093/nar/gkt754", "volume": "41", "author": "BM Lamb", "year": "2013", "unstructured": "Lamb BM, Mercer AC, Barbas CF (2013) Directed evolution of the TALE N-terminal domain for recognition of all 5\u2032 bases. Nucleic Acids Res 41:9779\u20139785", "journal-title": "Nucleic Acids Res"}, {"key": "504_CR29", "doi-asserted-by": "crossref", "first-page": "2381", "DOI": "10.1099/vir.0.000139", "volume": "96", "author": "C Li", "year": "2015", "unstructured": "Li C, Guan X, Du T et al (2015) Inhibition of HIV-1 infection of primary CD4 + T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. J Gen Virol 96:2381\u20132393", "journal-title": "J Gen Virol"}, {"key": "504_CR30", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1038/cr.2016.142", "volume": "27", "author": "X Liu", "year": "2017", "unstructured": "Liu X, Zhang Y, Cheng C et al (2017) CRISPR\u2013Cas9-mediated multiplex gene editing in CAR-T cells. Cell Res 27:154\u2013157", "journal-title": "Cell Res"}, {"key": "504_CR31", "doi-asserted-by": "crossref", "first-page": "949", "DOI": "10.1016/j.ymthe.2017.02.005", "volume": "25", "author": "DT MacLeod", "year": "2017", "unstructured": "MacLeod DT, Antony J, Martin AJ et al (2017) Integration of a CD19 CAR into the TCR alpha chain locus streamlines production of allogeneic gene-edited CAR T cells. Mol Ther 25:949\u2013961", "journal-title": "Mol Ther"}, {"key": "504_CR32", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1038/nrmicro2577", "volume": "9", "author": "KS Makarova", "year": "2011", "unstructured": "Makarova KS, Haft DH, Barrangou R et al (2011) Evolution and classification of the CRISPR\u2013Cas systems. Nat Rev Microbiol 9:467\u2013477", "journal-title": "Nat Rev Microbiol"}, {"key": "504_CR33", "doi-asserted-by": "crossref", "first-page": "823", "DOI": "10.1126/science.1232033", "volume": "339", "author": "P Mali", "year": "2013", "unstructured": "Mali P, Yang L, Esvelt KM et al (2013) RNA-guided human genome engineering via Cas9. Science 339:823\u2013826", "journal-title": "Science"}, {"key": "504_CR34", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1016/j.stem.2014.10.004", "volume": "15", "author": "PK Mandal", "year": "2014", "unstructured": "Mandal PK, Ferreira LM, Collins R et al (2014) Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15:643\u2013652", "journal-title": "Cell Stem Cell"}, {"issue": "2 Suppl", "key": "504_CR35", "doi-asserted-by": "crossref", "first-page": "1323", "DOI": "10.1590/0001-3765201520140710", "volume": "87", "author": "M Martins-Rocha", "year": "2015", "unstructured": "Martins-Rocha M, Cavalheiro GM, Matos-Rodrigues GE et al (2015) From gene targeting to genome editing: transgenic animal applications and beyond. An Acad Bras Cienc 87(2 Suppl):1323\u20131348", "journal-title": "An Acad Bras Cienc"}, {"key": "504_CR36", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1038/nbt.3190", "volume": "33", "author": "T Maruyama", "year": "2015", "unstructured": "Maruyama T, Dougan SK, Truttmann MC et al (2015) Increasing the efficiency of precise genome editing with CRISPR\u2013Cas9 by inhibition of nonhomologous end joinig. Nat Biotechnol 33:538\u2013542", "journal-title": "Nat Biotechnol"}, {"key": "504_CR37", "doi-asserted-by": "crossref", "first-page": "2087", "DOI": "10.1158/0008-5472.CAN-15-3352", "volume": "76", "author": "L Menger", "year": "2016", "unstructured": "Menger L, Sledzinska A, Bergerhoff K et al (2016) TALEN-mediated inactivation of PD-1 in tumor-reactive lymphocytes promotes intratumoral T-cell persistence and rejection of established tumors. Cancer Res 76:2087\u20132093", "journal-title": "Cancer Res"}, {"key": "504_CR38", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1038/nbt.1755", "volume": "29", "author": "JC Miller", "year": "2011", "unstructured": "Miller JC, Tan S, Qiao G et al (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29:143\u2013148", "journal-title": "Nat Biotechnol"}, {"key": "504_CR39", "first-page": "19", "volume": "6", "author": "AA Nemudryi", "year": "2014", "unstructured": "Nemudryi AA, Valetdinova KR, Medvedev SP et al (2014) TALEN and CRISPR/Cas genome editing systems: tools of discovery. Acta Naturae 6:19\u201340", "journal-title": "Acta Naturae"}, {"key": "504_CR40", "doi-asserted-by": "crossref", "first-page": "935", "DOI": "10.1016/j.cell.2014.02.001", "volume": "156", "author": "H Nishimasu", "year": "2014", "unstructured": "Nishimasu H, Ran FA, Hsu PD et al (2014) Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156:935\u2013949", "journal-title": "Cell"}, {"key": "504_CR41", "doi-asserted-by": "crossref", "first-page": "808", "DOI": "10.1038/nbt1410", "volume": "26", "author": "EE Perez", "year": "2008", "unstructured": "Perez EE, Wang J, Miller JC et al (2008) Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26:808\u2013816", "journal-title": "Nat Biotechnol"}, {"key": "504_CR42", "doi-asserted-by": "crossref", "first-page": "e0004", "DOI": "10.5041/RMMJ.10179", "volume": "6", "author": "K Perica", "year": "2015", "unstructured": "Perica K, Varela JC, Oelke M et al (2015) Adoptive T cell immunotherapy for cancer. Rambam Maimonides Med J 6:e0004", "journal-title": "Rambam Maimonides Med J"}, {"key": "504_CR43", "doi-asserted-by": "crossref", "first-page": "3853", "DOI": "10.1158/0008-5472.CAN-14-3321", "volume": "75", "author": "L Poirot", "year": "2015", "unstructured": "Poirot L, Philip B, Schiffer-Mannioui C et al (2015) Multiplex genome-edited T-cell manufacturing platform for \u201coff-the-shelf\u201d adoptive T-cell immunotherapies. Cancer Res 75:3853\u20133864", "journal-title": "Cancer Res"}, {"key": "504_CR44", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1038/nm.2700", "volume": "18", "author": "E Provasi", "year": "2012", "unstructured": "Provasi E, Genovese P, Lombardo A et al (2012) Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer. Nat Med 18:807\u2013815", "journal-title": "Nat Med"}, {"key": "504_CR45", "doi-asserted-by": "crossref", "first-page": "eaaj2013", "DOI": "10.1126/scitranslmed.aaj2013", "volume": "9", "author": "W Qasim", "year": "2017", "unstructured": "Qasim W, Zhan H, Samarasinghe S et al (2017) Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells. Sci Transl Med 9 eaaj2013", "journal-title": "Sci Transl Med"}, {"key": "504_CR46", "doi-asserted-by": "crossref", "first-page": "1380", "DOI": "10.1016/j.cell.2013.08.021", "volume": "154", "author": "FA Ran", "year": "2013", "unstructured": "Ran FA, Hsu PD, Lin CY et al (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154:1380\u20131389", "journal-title": "Cell"}, {"key": "504_CR47", "doi-asserted-by": "crossref", "first-page": "10437", "DOI": "10.1073/pnas.1512503112", "volume": "112", "author": "K Schumann", "year": "2015", "unstructured": "Schumann K, Lin S, Boyer E et al (2015) Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci USA 112:10437\u201310442", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "504_CR48", "doi-asserted-by": "crossref", "first-page": "1777", "DOI": "10.1182/blood-2014-12-615492", "volume": "126", "author": "R Sharma", "year": "2015", "unstructured": "Sharma R, Anguela XM, Doyon Y et al (2015) In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126:1777\u20131784", "journal-title": "Blood"}, {"key": "504_CR49", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1038/nmeth.2857", "volume": "11", "author": "B Shen", "year": "2014", "unstructured": "Shen B, Zhang W, Zhang J et al (2014) Efficient genome modification by CRISPR\u2013Cas9 nickase with minimal off-target effects. Nat Methods 11:399\u2013402", "journal-title": "Nat Methods"}, {"key": "504_CR50", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.2174/156652311794520111", "volume": "11", "author": "G Silva", "year": "2011", "unstructured": "Silva G, Poirot L, Galetto R et al (2011) Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr Gene Ther 11:11\u201327", "journal-title": "Curr Gene Ther"}, {"key": "504_CR51", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/j.str.2010.12.003", "volume": "19", "author": "BL Stoddard", "year": "2011", "unstructured": "Stoddard BL (2011) Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 19:7\u201315", "journal-title": "Structure"}, {"key": "504_CR52", "doi-asserted-by": "crossref", "first-page": "20070", "DOI": "10.1038/srep20070", "volume": "6", "author": "S Su", "year": "2016", "unstructured": "Su S, Hu B, Shao J et al (2016) CRISPR\u2013Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep 6:20070", "journal-title": "Sci Rep"}, {"key": "504_CR53", "doi-asserted-by": "crossref", "first-page": "e1249558", "DOI": "10.1080/2162402X.2016.1249558", "volume": "6", "author": "S Su", "year": "2017", "unstructured": "Su S, Zou Z, Chen F et al (2017) CRISPR\u2013Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology 6:e1249558", "journal-title": "Oncoimmunology"}, {"key": "504_CR54", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1016/j.cell.2014.09.039", "volume": "159", "author": "ME Tanenbaum", "year": "2014", "unstructured": "Tanenbaum ME, Gilbert LA, Qi LS et al (2014) A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159:635\u2013646", "journal-title": "Cell"}, {"key": "504_CR55", "doi-asserted-by": "crossref", "first-page": "901", "DOI": "10.1056/NEJMoa1300662", "volume": "370", "author": "P Tebas", "year": "2014", "unstructured": "Tebas P, Stein D, Tang WW et al (2014) Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370:901\u2013910", "journal-title": "N Engl J Med"}, {"key": "504_CR56", "doi-asserted-by": "crossref", "first-page": "1416", "DOI": "10.1042/BST20130056", "volume": "41", "author": "RM Terns", "year": "2013", "unstructured": "Terns RM, Terns MP (2013) The RNA- and DNA-targeting CRISPR\u2013Cas immune systems of Pyrococcus furiosus. Biochem Soc Trans 41:1416\u20131421", "journal-title": "Biochem Soc Trans"}, {"key": "504_CR57", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1038/nbt.2908", "volume": "32", "author": "SQ Tsai", "year": "2014", "unstructured": "Tsai SQ, Wyvekens N, Khayter C et al (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32:569\u2013576", "journal-title": "Nat Biotechnol"}, {"key": "504_CR58", "doi-asserted-by": "crossref", "first-page": "355ra116", "DOI": "10.1126/scitranslmed.aaf8621", "volume": "8", "author": "CJ Turtle", "year": "2016", "unstructured": "Turtle CJ, Hanafi LA, Berger C et al (2016) Immunotherapy of non-Hodgkin lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells. Sci Transl Med 8:355ra116", "journal-title": "Sci Transl Med"}, {"key": "504_CR59", "doi-asserted-by": "crossref", "first-page": "10972", "DOI": "10.1073/pnas.1005802107", "volume": "107", "author": "MM Loenen van", "year": "2010", "unstructured": "van Loenen MM, de Boer R, Amir AL et al (2010) Mixed T cell receptor dimers harbor potentially harmful neoreactivity. Proc Natl Acad Sci USA 107:10972\u201310977", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "Pt 6", "key": "504_CR60", "first-page": "1966", "volume": "155", "author": "JR Ploeg van der", "year": "2009", "unstructured": "van der Ploeg JR (2009) Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages. Microbiology 155(Pt 6):1966\u20131976", "journal-title": "Microbiology"}, {"key": "504_CR61", "doi-asserted-by": "crossref", "first-page": "e30", "DOI": "10.1093/nar/gkv1121", "volume": "44", "author": "J Wang", "year": "2016", "unstructured": "Wang J, DeClercq JJ, Hayward SB et al (2016) Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery. Nucleic Acids Res 44:e30", "journal-title": "Nucleic Acids Res"}, {"key": "504_CR62", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1038/nbt.3471", "volume": "34", "author": "H Yin", "year": "2016", "unstructured": "Yin H, Song CQ, Dorkin JR et al (2016) Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol 34:328\u2013333", "journal-title": "Nat Biotechnol"}, {"key": "504_CR63", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1186/1471-2105-15-191", "volume": "15", "author": "M Zaslavskiy", "year": "2014", "unstructured": "Zaslavskiy M, Bertonati C, Duchateau P et al (2014) Efficient design of meganucleases using a machine learning approach. BMC Bioinform 15:191", "journal-title": "BMC Bioinform"}], "container-title": ["Archivum Immunologiae et Therapiae Experimentalis"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s00005-018-0504-z/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00005-018-0504-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00005-018-0504-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 11]], "date-time": "2018-07-11T07:27:36Z", "timestamp": 1531294056000}, "score": 25.29527, "issued": {"date-parts": [[2018, 1, 17]]}, "references-count": 63, "journal-issue": {"published-print": {"date-parts": [[2018, 8]]}, "issue": "4"}, "alternative-id": ["504"], "URL": "http://dx.doi.org/10.1007/s00005-018-0504-z", "relation": {"cites": []}, "ISSN": ["0004-069X", "1661-4917"], "issn-type": [{"value": "0004-069X", "type": "print"}, {"value": "1661-4917", "type": "electronic"}], "subject": ["Immunology", "Immunology and Allergy", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T15:38:33Z", "timestamp": 1525534713583}, "reference-count": 29, "publisher": "Springer Nature", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2012, 5, 30]], "date-time": "2012-05-30T00:00:00Z", "timestamp": 1338336000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BMC Cancer"], "published-print": {"date-parts": [[2012, 12]]}, "DOI": "10.1186/1471-2407-12-209", "type": "journal-article", "created": {"date-parts": [[2012, 8, 3]], "date-time": "2012-08-03T14:14:30Z", "timestamp": 1344003270000}, "source": "Crossref", "is-referenced-by-count": 2, "title": ["Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice"], "prefix": "10.1186", "volume": "12", "author": [{"given": "Agnieszka M", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Patrick", "family": "O\u2019Leary", "sequence": "additional", "affiliation": []}, {"given": "John J", "family": "Callanan", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Crown", "sequence": "additional", "affiliation": []}, {"given": "William M", "family": "Gallagher", "sequence": "additional", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 5, 30]]}, "reference": [{"issue": "5", "key": "3197_CR1", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1586/erm.09.31", "volume": "9", "author": "P Taneja", "year": "2009", "unstructured": "Taneja P, Frazier DP, Kendig RD, Maglic D, Sugiyama T, Kai F, Taneja NK, Inoue K: MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer. Expert Rev Mol Diagn. 2009, 9 (5): 423-440. 10.1586/erm.09.31.", "journal-title": "Expert Rev Mol Diagn"}, {"issue": "5", "key": "3197_CR2", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1038/nrc2127", "volume": "7", "author": "J Ursini-Siegel", "year": "2007", "unstructured": "Ursini-Siegel J, Schade B, Cardiff RD, Muller WJ: Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat Rev Cancer. 2007, 7 (5): 389-397. 10.1038/nrc2127.", "journal-title": "Nat Rev Cancer"}, {"issue": "12", "key": "3197_CR3", "doi-asserted-by": "publisher", "first-page": "3319", "DOI": "10.1128/MCB.01803-08", "volume": "29", "author": "K Pedersen", "year": "2009", "unstructured": "Pedersen K, Angelini PD, Laos S, Bach-Faig A, Cunningham MP, Ferrer-Ramon C, Luque-Garcia A, Garcia-Castillo J, Parra-Palau JL, Scaltriti M, et al: A naturally occurring HER2 carboxy-terminalfragment promotes mammary tumor growth and metastasis. Mol Cell Biol. 2009, 29 (12): 3319-3331. 10.1128/MCB.01803-08.", "journal-title": "Mol Cell Biol"}, {"issue": "2", "key": "3197_CR4", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O", "volume": "23", "author": "KY Kwong", "year": "1998", "unstructured": "Kwong KY, Hung MC: A novel splice variant of HER2 with increased transformation activity. Mol Carcinog. 1998, 23 (2): 62-68. 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O.", "journal-title": "Mol Carcinog"}, {"issue": "6482", "key": "3197_CR5", "doi-asserted-by": "publisher", "first-page": "669", "DOI": "10.1038/369669a0", "volume": "369", "author": "TC Wang", "year": "1994", "unstructured": "Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994, 369 (6482): 669-671. 10.1038/369669a0.", "journal-title": "Nature"}, {"issue": "4", "key": "3197_CR6", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1016/0092-8674(87)90449-1", "volume": "49", "author": "E Sinn", "year": "1987", "unstructured": "Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P: Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 1987, 49 (4): 465-475. 10.1016/0092-8674(87)90449-1.", "journal-title": "Cell"}, {"issue": "3", "key": "3197_CR7", "doi-asserted-by": "publisher", "first-page": "627", "DOI": "10.1016/0092-8674(84)90257-5", "volume": "38", "author": "TA Stewart", "year": "1984", "unstructured": "Stewart TA, Pattengale PK, Leder P: Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell. 1984, 38 (3): 627-637. 10.1016/0092-8674(84)90257-5.", "journal-title": "Cell"}, {"issue": "3", "key": "3197_CR8", "doi-asserted-by": "publisher", "first-page": "954", "DOI": "10.1128/MCB.12.3.954", "volume": "12", "author": "CT Guy", "year": "1992", "unstructured": "Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992, 12 (3): 954-961.", "journal-title": "Mol Cell Biol"}, {"key": "3197_CR9", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1186/1471-2407-10-397", "volume": "10", "author": "KD Lynn", "year": "2010", "unstructured": "Lynn KD, Udugamasooriya DG, Roland CL, Castrillon DH, Kodadek TJ, Brekken RA: GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer. BMC Cancer. 2010, 10: 397-10.1186/1471-2407-10-397.", "journal-title": "BMC Cancer"}, {"issue": "11", "key": "3197_CR10", "doi-asserted-by": "publisher", "first-page": "e7669", "DOI": "10.1371/journal.pone.0007669", "volume": "4", "author": "CL Roland", "year": "2009", "unstructured": "Roland CL, Lynn KD, Toombs JE, Dineen SP, Udugamasooriya DG, Brekken RA: Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. PLoS One. 2009, 4 (11): e7669-10.1371/journal.pone.0007669.", "journal-title": "PLoS One"}, {"issue": "3", "key": "3197_CR11", "first-page": "317", "volume": "220", "author": "K O'Neill", "year": "2010", "unstructured": "O'Neill K, Lyons SK, Gallagher WM, Curran KM, Byrne AT: Bioluminescent imaging: a critical tool in pre-clinical oncology research. J Pathol. 2010, 220 (3): 317-327.", "journal-title": "J Pathol"}, {"issue": "6", "key": "3197_CR12", "doi-asserted-by": "publisher", "first-page": "975", "DOI": "10.4155/fmc.10.25", "volume": "2", "author": "MF Penet", "year": "2010", "unstructured": "Penet MF, Mikhaylova M, Li C, Krishnamachary B, Glunde K, Pathak AP, Bhujwalla ZM: Applications of molecular MRI and optical imaging in cancer. Future Med Chem. 2010, 2 (6): 975-988. 10.4155/fmc.10.25.", "journal-title": "Future Med Chem"}, {"issue": "3\u20134", "key": "3197_CR13", "doi-asserted-by": "publisher", "first-page": "102", "DOI": "10.1016/j.drudis.2009.12.003", "volume": "15", "author": "R van der Meel", "year": "2010", "unstructured": "van der Meel R, Gallagher WM, Oliveira S, O'Connor AE, Schiffelers RM, Byrne AT: Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies. Drug Discov Today. 2010, 15 (3\u20134): 102-114.", "journal-title": "Drug Discov Today"}, {"key": "3197_CR14", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.2174/1875397301004010043", "volume": "4", "author": "A Paguio", "year": "2010", "unstructured": "Paguio A, Stecha P, Wood KV, Fan F: Improved dual-luciferase reporter assays for nuclear receptors. Current Chem Genomics. 2010, 4: 43-49. 10.2174/1875397301004010043.", "journal-title": "Current Chem Genomics"}, {"issue": "6", "key": "3197_CR15", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1016/S1535-6108(02)00212-X", "volume": "2", "author": "SE Moody", "year": "2002", "unstructured": "Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA: Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2002, 2 (6): 451-461. 10.1016/S1535-6108(02)00212-X.", "journal-title": "Cancer Cell"}, {"issue": "4", "key": "3197_CR16", "doi-asserted-by": "publisher", "first-page": "e18727", "DOI": "10.1371/journal.pone.0018727", "volume": "6", "author": "C Marchini", "year": "2011", "unstructured": "Marchini C, Gabrielli F, Iezzi M, Zenobi S, Montani M, Pietrella L, Kalogris C, Rossini A, Ciravolo V, Castagnoli L, et al: The human splice variant Delta16HER2 induces rapid tumor onset in a reporter transgenic mouse. PLoS One. 2011, 6 (4): e18727-10.1371/journal.pone.0018727.", "journal-title": "PLoS One"}, {"issue": "6", "key": "3197_CR17", "doi-asserted-by": "publisher", "first-page": "1391", "DOI": "10.1210/me.2005-0426", "volume": "20", "author": "T Vargo-Gogola", "year": "2006", "unstructured": "Vargo-Gogola T, Heckman BM, Gunther EJ, Chodosh LA, Rosen JM: P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland. Mol Endocrinol. 2006, 20 (6): 1391-1405.", "journal-title": "Mol Endocrinol"}, {"key": "3197_CR18", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1146/annurev.ph.58.030196.001233", "volume": "58", "author": "LC Samuelson", "year": "1996", "unstructured": "Samuelson LC: Transgenic approaches to salivary gland research. Annu Rev Physiol. 1996, 58: 209-229. 10.1146/annurev.ph.58.030196.001233.", "journal-title": "Annu Rev Physiol"}, {"issue": "24", "key": "3197_CR19", "first-page": "7166", "volume": "62", "author": "F Ahmed", "year": "2002", "unstructured": "Ahmed F, Wyckoff J, Lin EY, Wang W, Wang Y, Hennighausen L, Miyazaki J, Jones J, Pollard JW, Condeelis JS, et al: GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res. 2002, 62 (24): 7166-7169.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "3197_CR20", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1182/blood-2003-06-1820", "volume": "103", "author": "N Zhang", "year": "2004", "unstructured": "Zhang N, Fang Z, Contag PR, Purchio AF, West DB: Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood. 2004, 103 (2): 617-626. 10.1182/blood-2003-06-1820.", "journal-title": "Blood"}, {"issue": "21", "key": "3197_CR21", "first-page": "7042", "volume": "63", "author": "SK Lyons", "year": "2003", "unstructured": "Lyons SK, Meuwissen R, Krimpenfort P, Berns A: The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res. 2003, 63 (21): 7042-7046.", "journal-title": "Cancer Res"}, {"issue": "21", "key": "3197_CR22", "doi-asserted-by": "publisher", "first-page": "4323", "DOI": "10.1093/nar/25.21.4323", "volume": "25", "author": "KU Wagner", "year": "1997", "unstructured": "Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L: Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 1997, 25 (21): 4323-4330. 10.1093/nar/25.21.4323.", "journal-title": "Nucleic Acids Res"}, {"issue": "3", "key": "3197_CR23", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1007/s11248-009-9329-1", "volume": "19", "author": "Q Zhang", "year": "2010", "unstructured": "Zhang Q, Triplett AA, Harms DW, Lin WC, Creamer BA, Rizzino A, Wagner KU: Temporally and spatially controlled expression of transgenes in embryonic and adult tissues. Trans Res. 2010, 19 (3): 499-509. 10.1007/s11248-009-9329-1.", "journal-title": "Trans Res"}, {"issue": "1", "key": "3197_CR24", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1073/pnas.0509459103", "volume": "103", "author": "M Safran", "year": "2006", "unstructured": "Safran M, Kim WY, O'Connell F, Flippin L, Gunzler V, Horner JW, Depinho RA, Kaelin WG: Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci U S A. 2006, 103 (1): 105-110. 10.1073/pnas.0509459103.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "3", "key": "3197_CR25", "doi-asserted-by": "publisher", "first-page": "e18269", "DOI": "10.1371/journal.pone.0018269", "volume": "6", "author": "SJ Goldman", "year": "2011", "unstructured": "Goldman SJ, Chen E, Taylor R, Zhang S, Petrosky W, Reiss M, Jin S: Use of the ODD-luciferase transgene for the non-invasive imaging of spontaneous tumors in mice. PLoS One. 2011, 6 (3): e18269-10.1371/journal.pone.0018269.", "journal-title": "PLoS One"}, {"issue": "4", "key": "3197_CR26", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1002/dvg.20480", "volume": "47", "author": "BA Creamer", "year": "2009", "unstructured": "Creamer BA, Triplett AA, Wagner KU: Longitudinal analysis of mammogenesis using a novel tetracycline-inducible mouse model and in vivo imaging. Genesis. 2009, 47 (4): 234-245. 10.1002/dvg.20480.", "journal-title": "Genesis"}, {"issue": "9", "key": "3197_CR27", "doi-asserted-by": "publisher", "first-page": "659", "DOI": "10.1038/nrc2193", "volume": "7", "author": "T Vargo-Gogola", "year": "2007", "unstructured": "Vargo-Gogola T, Rosen JM: Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007, 7 (9): 659-672. 10.1038/nrc2193.", "journal-title": "Nat Rev Cancer"}, {"issue": "1", "key": "3197_CR28", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1038/8743", "volume": "22", "author": "X Xu", "year": "1999", "unstructured": "Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX: Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet. 1999, 22 (1): 37-43. 10.1038/8743.", "journal-title": "Nat Genet"}, {"issue": "2", "key": "3197_CR29", "doi-asserted-by": "publisher", "first-page": "024007", "DOI": "10.1117/1.2717898", "volume": "12", "author": "C Kuo", "year": "2007", "unstructured": "Kuo C, Coquoz O, Troy TL, Xu H, Rice BW: Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. J Biomed Opt. 2007, 12 (2): 024007-10.1117/1.2717898.", "journal-title": "J Biomed Opt"}], "container-title": ["BMC Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/1471-2407-12-209.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/1471-2407-12-209/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/1471-2407-12-209", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 7, 12]], "date-time": "2016-07-12T19:38:13Z", "timestamp": 1468352293000}, "score": 22.219082, "issued": {"date-parts": [[2012, 5, 30]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[2012, 12]]}, "issue": "1"}, "alternative-id": ["3197"], "URL": "http://dx.doi.org/10.1186/1471-2407-12-209", "relation": {"cites": []}, "ISSN": ["1471-2407"], "issn-type": [{"value": "1471-2407", "type": "electronic"}], "article-number": "209"}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T09:02:48Z", "timestamp": 1525770168198}, "reference-count": 0, "publisher": "Spandidos Publications", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int J Oncol"], "DOI": "10.3892/ijo.21.6.1347", "type": "journal-article", "created": {"date-parts": [[2014, 3, 10]], "date-time": "2014-03-10T07:28:29Z", "timestamp": 1394436509000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells"], "prefix": "10.3892", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "C\u00e9cile", "family": "Bougeret", "sequence": "additional", "affiliation": []}, {"given": "Yigong", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[2002, 12, 1]]}, "container-title": ["International Journal of Oncology"], "link": [{"URL": "https://spandidos-publications.com/10.3892/ijo.21.6.1347/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T09:40:47Z", "timestamp": 1493286047000}, "score": 21.810154, "issued": {"date-parts": [[2002, 12, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3892/ijo.21.6.1347", "ISSN": ["1019-6439", "1791-2423"], "issn-type": [{"value": "1019-6439", "type": "print"}, {"value": "1791-2423", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 12, 12]], "date-time": "2018-12-12T09:03:17Z", "timestamp": 1544605397267}, "reference-count": 0, "publisher": "Spandidos Publications", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int J Oncol"], "DOI": "10.3892/ijo.29.6.1453", "type": "journal-article", "created": {"date-parts": [[2014, 3, 10]], "date-time": "2014-03-10T07:31:40Z", "timestamp": 1394436700000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion"], "prefix": "10.3892", "author": [{"given": "Yigong", "family": "Fu", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Ron", "family": "Avraham", "sequence": "additional", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[2006, 12, 1]]}, "container-title": ["International Journal of Oncology"], "link": [{"URL": "https://spandidos-publications.com/10.3892/ijo.29.6.1453/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T09:48:42Z", "timestamp": 1493286522000}, "score": 21.810154, "issued": {"date-parts": [[2006, 12, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3892/ijo.29.6.1453", "ISSN": ["1019-6439", "1791-2423"], "issn-type": [{"value": "1019-6439", "type": "print"}, {"value": "1791-2423", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T07:23:02Z", "timestamp": 1525764182910}, "publisher-location": "Cham", "reference-count": 0, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319268460", "type": "print"}, {"value": "9783319268484", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-26848-4_12", "type": "book-chapter", "created": {"date-parts": [[2016, 3, 29]], "date-time": "2016-03-29T21:20:00Z", "timestamp": 1459286400000}, "page": "125-138", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Public\u2013Private Partnership and the Development of Transport Infrastructure in Poland: The Analysis of Critical Success Factors"], "prefix": "10.1007", "author": [{"given": "Beata", "family": "Zagozdzon", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 3, 30]]}, "container-title": ["Transport Development Challenges in the Twenty-First Century", "Springer Proceedings in Business and Economics"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-26848-4_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 3, 29]], "date-time": "2016-03-29T21:20:03Z", "timestamp": 1459286403000}, "score": 18.41459, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319268460", "9783319268484"], "references-count": 0, "URL": "http://dx.doi.org/10.1007/978-3-319-26848-4_12", "ISSN": ["2198-7246", "2198-7254"], "issn-type": [{"value": "2198-7246", "type": "print"}, {"value": "2198-7254", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 7, 31]], "date-time": "2018-07-31T15:11:06Z", "timestamp": 1533049866177}, "reference-count": 0, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4031, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[2004, 9, 1]]}, "DOI": "10.1002/cncr.20442", "type": "journal-article", "created": {"date-parts": [[2004, 7, 14]], "date-time": "2004-07-14T22:02:48Z", "timestamp": 1089842568000}, "page": "1018-1027", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Differential expression of Csk homologous kinase(CHK) in normal brain and brain tumors"], "prefix": "10.1002", "volume": "101", "author": [{"given": "Sun-Ok", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Shalom", "family": "Avraham", "sequence": "additional", "affiliation": []}, {"given": "Shuxian", "family": "Jiang", "sequence": "additional", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Yigong", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "Hava Karsenty", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2004, 8, 18]]}, "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.20442", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.20442", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 31]], "date-time": "2018-07-31T14:43:41Z", "timestamp": 1533048221000}, "score": 17.39752, "issued": {"date-parts": [[2004, 8, 18]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 9, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/cncr.20442", "ISSN": ["0008-543X", "1097-0142"], "issn-type": [{"value": "0008-543X", "type": "print"}, {"value": "1097-0142", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T22:39:05Z", "timestamp": 1525473545284}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 6, 1]], "date-time": "2006-06-01T00:00:00Z", "timestamp": 1149120000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cellular Signalling"], "published-print": {"date-parts": [[2006, 6]]}, "DOI": "10.1016/j.cellsig.2005.07.016", "type": "journal-article", "created": {"date-parts": [[2005, 9, 16]], "date-time": "2005-09-16T16:40:17Z", "timestamp": 1126888817000}, "page": "871-881", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner"], "prefix": "10.1016", "volume": "18", "author": [{"given": "Radoslaw", "family": "Zagozdzon", "sequence": "first", "affiliation": []}, {"given": "Rafal", "family": "Kaminski", "sequence": "additional", "affiliation": []}, {"given": "Yigong", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "Wei", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "Cecile", "family": "Bougeret", "sequence": "additional", "affiliation": []}, {"given": "Hava Karsenty", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cellular Signalling"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0898656805001865?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0898656805001865?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2015, 11, 15]], "date-time": "2015-11-15T20:07:40Z", "timestamp": 1447618060000}, "score": 17.39752, "issued": {"date-parts": [[2006, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 6]]}, "issue": "6"}, "alternative-id": ["S0898656805001865"], "URL": "http://dx.doi.org/10.1016/j.cellsig.2005.07.016", "ISSN": ["0898-6568"], "issn-type": [{"value": "0898-6568", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T19:25:06Z", "timestamp": 1525289106082}, "reference-count": 0, "publisher": "Springer Nature", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Archives of Dermatological Research"], "published-print": {"date-parts": [[1998, 12, 14]]}, "DOI": "10.1007/s004030050375", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T08:36:27Z", "timestamp": 1030264587000}, "page": "696-700", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Calcitriol enhances antineoplastic and antiangiogenic effects of interleukin-12"], "prefix": "10.1007", "volume": "290", "author": [{"given": "D.", "family": "Nowicka", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Slawomir", "family": "Majewski", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Marezak", "sequence": "additional", "affiliation": []}, {"given": "Stefania", "family": "Jablonska", "sequence": "additional", "affiliation": []}, {"given": "Werner", "family": "Bollag", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Archives of Dermatological Research"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s004030050375", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2013, 3, 23]], "date-time": "2013-03-23T13:14:17Z", "timestamp": 1364044457000}, "score": 17.39752, "issued": {"date-parts": [[1998, 12, 14]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 12, 14]]}, "issue": "12"}, "alternative-id": ["B8UXYH7H2RNECMTX"], "URL": "http://dx.doi.org/10.1007/s004030050375", "ISSN": ["0340-3696", "1432-069X"], "issn-type": [{"value": "0340-3696", "type": "print"}, {"value": "1432-069X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T09:37:34Z", "timestamp": 1525340254657}, "reference-count": 34, "publisher": "American Society for Biochemistry & Molecular Biology (ASBMB)", "issue": "39", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Biol. Chem."], "published-print": {"date-parts": [[2002, 9, 27]]}, "DOI": "10.1074/jbc.m206018200", "type": "journal-article", "created": {"date-parts": [[2002, 9, 20]], "date-time": "2002-09-20T18:02:52Z", "timestamp": 1032544972000}, "page": "36465-36470", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Csk Homologous Kinase (CHK) and ErbB-2 Interactions Are Directly Coupled with CHK Negative Growth Regulatory Function in Breast Cancer"], "prefix": "10.1074", "volume": "277", "author": [{"given": "Soyoun", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Alan", "family": "Meisler", "sequence": "additional", "affiliation": []}, {"given": "James D.", "family": "Baleja", "sequence": "additional", "affiliation": []}, {"given": "Yigong", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "Shalom", "family": "Avraham", "sequence": "additional", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "28", "published-online": {"date-parts": [[2002, 7, 16]]}, "reference": [{"key": "2017062210244382000_277.39.36465.1", "DOI": "10.1038/bjc.1991.28", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.2", "DOI": "10.1073/pnas.85.9.3044", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.3", "DOI": "10.1101/gad.9.11.1309", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.4", "DOI": "10.1038/319230a0", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.5", "DOI": "10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.6", "author": "Muthuswamy", "volume": "11", "first-page": "1801", "year": "1995", "journal-title": "Oncogene"}, {"key": "2017062210244382000_277.39.36465.7", "author": "Muthuswamy", "volume": "11", "first-page": "271", "year": "1995", "journal-title": "Oncogene"}, {"key": "2017062210244382000_277.39.36465.8", "DOI": "10.1126/science.2885917", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.9", "author": "Ben-Levy", "volume": "267", "first-page": "17304", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2017062210244382000_277.39.36465.10", "author": "Ben-Levy", "volume": "13", "first-page": "3302", "year": "1994", "journal-title": "EMBO J."}, {"key": "2017062210244382000_277.39.36465.11", "author": "Dankort", "volume": "17", "first-page": "5410", "year": "1997", "journal-title": "Mol. Cell. Biol.", "DOI": "10.1128/MCB.17.9.5410", "doi-asserted-by": "crossref"}, {"key": "2017062210244382000_277.39.36465.12", "author": "Akiyama", "volume": "11", "first-page": "833", "year": "1991", "journal-title": "Mol. Cell. Biol.", "DOI": "10.1128/MCB.11.2.833", "doi-asserted-by": "crossref"}, {"key": "2017062210244382000_277.39.36465.13", "DOI": "10.1074/jbc.272.3.1856", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.14", "DOI": "10.1074/jbc.273.7.4065", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.15", "DOI": "10.1074/jbc.M104209200", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.16", "DOI": "10.1073/pnas.91.7.2597", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.17", "DOI": "10.1073/pnas.91.11.4975", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.18", "DOI": "10.1074/jbc.272.2.1355", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.19", "DOI": "10.1126/science.287.5460.1969", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.20", "DOI": "10.1038/358646a0", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.21", "DOI": "10.1016/0092-8674(93)90405-F", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.22", "DOI": "10.1038/385595a0", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.23", "DOI": "10.1038/nsb0298-156", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.24", "DOI": "10.1021/bi002700m", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.25", "author": "Rajagopal", "volume": "6", "first-page": "2624", "year": "1997", "journal-title": "Protein Sci.", "DOI": "10.1002/pro.5560061214", "doi-asserted-by": "crossref"}, {"key": "2017062210244382000_277.39.36465.26", "DOI": "10.1006/jmrb.1996.0175", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.27", "DOI": "10.1007/BF00227471", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.28", "DOI": "10.1146/annurev.cellbio.13.1.513", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.29", "DOI": "10.1016/0092-8674(93)90404-E", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.30", "DOI": "10.1006/jmbi.1999.3111", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.31", "DOI": "10.1006/jmbi.1999.3190", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.32", "DOI": "10.1128/JVI.75.4.1816-1823.2001", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.33", "DOI": "10.4049/jimmunol.164.8.4170", "doi-asserted-by": "publisher"}, {"key": "2017062210244382000_277.39.36465.34", "unstructured": "Murthy, T. V. S., and Webster, G. D. (2001) Protein Data Bank (www.rcsb.org/pdb."}], "container-title": ["Journal of Biological Chemistry"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1074/jbc.M206018200", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T12:23:03Z", "timestamp": 1498220583000}, "score": 17.39752, "issued": {"date-parts": [[2002, 7, 16]]}, "references-count": 34, "journal-issue": {"published-online": {"date-parts": [[2002, 9, 20]]}, "published-print": {"date-parts": [[2002, 9, 27]]}, "issue": "39"}, "alternative-id": ["10.1074/jbc.M206018200"], "URL": "http://dx.doi.org/10.1074/jbc.m206018200", "relation": {"cites": []}, "ISSN": ["0021-9258", "1083-351X"], "issn-type": [{"value": "0021-9258", "type": "print"}, {"value": "1083-351X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T09:02:47Z", "timestamp": 1525770167947}, "reference-count": 0, "publisher": "Spandidos Publications", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int J Oncol"], "DOI": "10.3892/ijo.21.1.197", "type": "journal-article", "created": {"date-parts": [[2014, 3, 10]], "date-time": "2014-03-10T07:28:16Z", "timestamp": 1394436496000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration"], "prefix": "10.3892", "author": [{"given": "Gina", "family": "McShan", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Shin-Young", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Sheila", "family": "Zrihan-Licht", "sequence": "additional", "affiliation": []}, {"given": "Yigong", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "Shalom", "family": "Avraham", "sequence": "additional", "affiliation": []}, {"given": "Hava", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[2002, 7, 1]]}, "container-title": ["International Journal of Oncology"], "link": [{"URL": "https://spandidos-publications.com/10.3892/ijo.21.1.197/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T09:40:15Z", "timestamp": 1493286015000}, "score": 17.39752, "issued": {"date-parts": [[2002, 7, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3892/ijo.21.1.197", "ISSN": ["1019-6439", "1791-2423"], "issn-type": [{"value": "1019-6439", "type": "print"}, {"value": "1791-2423", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 9, 21]], "date-time": "2018-09-21T11:42:42Z", "timestamp": 1537530162970}, "reference-count": 39, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2016, 11, 25]], "date-time": "2016-11-25T00:00:00Z", "timestamp": 1480032000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2016, 11, 25]], "date-time": "2016-11-25T00:00:00Z", "timestamp": 1480032000000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"name": "Parent/Bridge programme of the Foundation for Polish Science, co-financed by the European Union under the European Regional Development Fund", "award": []}, {"name": "National Science Center", "award": ["2012/07/B/NZ7/04183"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anat. Rec."], "published-print": {"date-parts": [[2017, 3]]}, "DOI": "10.1002/ar.23498", "type": "journal-article", "created": {"date-parts": [[2016, 10, 14]], "date-time": "2016-10-14T22:57:15Z", "timestamp": 1476485835000}, "page": "577-588", "source": "Crossref", "is-referenced-by-count": 2, "title": ["The Anatomy of Caprine Female Urethra and Characteristics of Muscle and Bone Marrow Derived Caprine Cells for Autologous Cell Therapy Testing"], "prefix": "10.1002", "volume": "300", "author": [{"given": "Anna", "family": "Burdzinska", "sequence": "first", "affiliation": [{"name": "Department of Immunology; Transplantology and Internal Medicine, Transplantation Institute, Medical University of Warsaw; Warsaw Poland"}]}, {"given": "Bartosz", "family": "Dybowski", "sequence": "additional", "affiliation": [{"name": "Department of Urology; Medical University of Warsaw; Warsaw Poland"}]}, {"given": "Weronika", "family": "Zarychta-Wisniewska", "sequence": "additional", "affiliation": [{"name": "Department of Immunology; Transplantology and Internal Medicine, Transplantation Institute, Medical University of Warsaw; Warsaw Poland"}]}, {"given": "Agnieszka", "family": "Kulesza", "sequence": "additional", "affiliation": [{"name": "Department of Immunology; Transplantology and Internal Medicine, Transplantation Institute, Medical University of Warsaw; Warsaw Poland"}]}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": [{"name": "Department of Immunology; Center of Biostructure Research, Medical University of Warsaw; Warsaw Poland"}, {"name": "Department of Bioinformatics; Institute of Biochemistry and Biophysics, Polish Academy of Sciences; Warsaw Poland"}]}, {"given": "Zdzislaw", "family": "Gajewski", "sequence": "additional", "affiliation": [{"name": "Department of Large Animal Diseases with Clinic Faculty of Veterinary Medicine; Warsaw University of Life Sciences (SGGW); Warsaw Poland"}]}, {"given": "Leszek", "family": "Paczek", "sequence": "additional", "affiliation": [{"name": "Department of Immunology; Transplantology and Internal Medicine, Transplantation Institute, Medical University of Warsaw; Warsaw Poland"}]}], "member": "311", "published-online": {"date-parts": [[2016, 11, 25]]}, "reference": [{"key": "10.1002/ar.23498-BIB0001|ar23498-cit-0001", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1590/S0074-02762004000600009", "article-title": "Biologic data of Macaca mulatta, Macaca fascicularis, and Saimiri sciureus used for research at the Fiocruz primate center", "volume": "99", "author": "Andrade", "year": "2004", "journal-title": "Mem Inst Oswaldo Cruz"}, {"key": "10.1002/ar.23498-BIB0002|ar23498-cit-0002", "doi-asserted-by": "crossref", "first-page": "1938", "DOI": "10.1016/j.juro.2013.04.052", "article-title": "Long-term structural and functional effects of autologous muscle precursor cell therapy in a nonhuman primate model of urinary sphincter deficiency", "volume": "190", "author": "Badra", "year": "2013", "journal-title": "J Urol"}, {"key": "10.1002/ar.23498-BIB0003|ar23498-cit-0003", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.1039/c1ib00058f", "article-title": "Patterning the differentiation of C2C12 skeletal myoblasts", "volume": "3", "author": "Bajaj", "year": "2011", "journal-title": "Integr Biol (Camb)"}, {"key": "10.1002/ar.23498-BIB0004|ar23498-cit-0004", "first-page": "493", "article-title": "Sodium ascorbate and basic fibroblast growth factor protect muscle-derived cells from H2O2-induced oxidative stress", "volume": "56", "author": "Burdzinska", "year": "2006", "journal-title": "Comp Med"}, {"key": "10.1002/ar.23498-BIB0005|ar23498-cit-0005", "doi-asserted-by": "crossref", "first-page": "736", "DOI": "10.1016/j.urology.2008.11.024", "article-title": "Preincubation with bFGF but not sodium ascorbate improves efficiency of autologous transplantation of muscle-derived cells into urethral wall", "volume": "73", "author": "Burdzinska", "year": "2009", "journal-title": "Urology"}, {"key": "10.1002/ar.23498-BIB0006|ar23498-cit-0006", "doi-asserted-by": "crossref", "first-page": "e741", "DOI": "10.1016/j.urology.2013.03.030", "article-title": "The effect of endoscopic administration of autologous porcine muscle-derived cells into the urethral sphincter", "volume": "82", "author": "Burdzinska", "year": "2013", "journal-title": "Urology"}, {"key": "10.1002/ar.23498-BIB0007|ar23498-cit-0007", "doi-asserted-by": "crossref", "first-page": "780", "DOI": "10.1016/j.urology.2003.10.035", "article-title": "Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency", "volume": "63", "author": "Chermansky", "year": "2004", "journal-title": "Urology"}, {"key": "10.1002/ar.23498-BIB0008|ar23498-cit-0008", "doi-asserted-by": "crossref", "first-page": "246134", "DOI": "10.1155/2013/246134", "article-title": "Comparative evaluation of human mesenchymal stem cells of fetal (Wharton's jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: Considerations for cytotherapy", "volume": "2013", "author": "Christodoulou", "year": "2013", "journal-title": "Stem Cells Int"}, {"key": "10.1002/ar.23498-BIB0009|ar23498-cit-0009", "first-page": "501", "article-title": "Clinical evaluation of a single daily dose of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch", "volume": "52", "author": "Claeys", "year": "2011", "journal-title": "Can Vet J"}, {"key": "10.1002/ar.23498-BIB0010|ar23498-cit-0010", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1002/nau.20998", "article-title": "Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence", "volume": "30", "author": "Corcos", "year": "2011", "journal-title": "Neurourol Urodyn"}, {"key": "10.1002/ar.23498-BIB0011|ar23498-cit-0011", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1002/nau.10009", "article-title": "Urethral pressure profile: Is it affected by position?", "volume": "21", "author": "Dorflinger", "year": "2002", "journal-title": "Neurourol Urodyn"}, {"key": "10.1002/ar.23498-BIB0012|ar23498-cit-0012", "doi-asserted-by": "crossref", "first-page": "2089", "DOI": "10.3727/096368911X623835", "article-title": "Muscle precursor cells for the restoration of irreversibly damaged sphincter function", "volume": "21", "author": "Eberli", "year": "2012", "journal-title": "Cell Transplant"}, {"key": "10.1002/ar.23498-BIB0013|ar23498-cit-0013", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1042/CBI20100586", "article-title": "Characterization of bone-marrow-derived rat mesenchymal stem cells depending on donor age", "volume": "35", "author": "Gala", "year": "2011", "journal-title": "Cell Biol Int"}, {"key": "10.1002/ar.23498-BIB0014|ar23498-cit-0014", "doi-asserted-by": "crossref", "first-page": "955", "DOI": "10.1007/BF02624469", "article-title": "Long-term maintenance of primary myogenic cultures on a reconstituted basement membrane", "volume": "26", "author": "Hartley", "year": "1990", "journal-title": "In Vitro Cell Dev Biol"}, {"key": "10.1002/ar.23498-BIB0015|ar23498-cit-0015", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1159/000381534", "article-title": "Isolation and characterization of CD271(+) stem cells derived from sheep dermal skin. Cells", "volume": "200", "author": "Jahroomishirazi", "year": "2014", "journal-title": "Tissues Organs"}, {"key": "10.1002/ar.23498-BIB1016|ar23498-cit-1016", "unstructured": "Jay J 2008 Urologic Anatomic Correlates"}, {"key": "10.1002/ar.23498-BIB0016|ar23498-cit-0016", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1080/10495398.2011.624651", "article-title": "Variation of telomerase activity and morphology in porcine mesenchymal stem cells and fibroblasts during prolonged in vitro culture", "volume": "22", "author": "Jeon", "year": "2011", "journal-title": "Anim Biotechnol"}, {"key": "10.1002/ar.23498-BIB0017|ar23498-cit-0017", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1177/1947603514548213", "article-title": "The role of cells in meniscal guided tissue regeneration: A proof of concept study in a goat model", "volume": "6", "author": "Julke", "year": "2015", "journal-title": "Cartilage"}, {"key": "10.1002/ar.23498-BIB0018|ar23498-cit-0018", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1159/000317322", "article-title": "Bone-marrow-derived mesenchymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model", "volume": "86", "author": "Kim", "year": "2011", "journal-title": "Urol Int"}, {"key": "10.1002/ar.23498-BIB0019|ar23498-cit-0019", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1111/j.1442-2042.2010.02471.x", "article-title": "Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter", "volume": "17", "author": "Kinebuchi", "year": "2010", "journal-title": "Int J Urol"}, {"key": "10.1002/ar.23498-BIB0020|ar23498-cit-0020", "doi-asserted-by": "crossref", "first-page": "3464", "DOI": "10.1002/art.11365", "article-title": "Stem cell therapy in a caprine model of osteoarthritis", "volume": "48", "author": "Murphy", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/ar.23498-BIB0021|ar23498-cit-0021", "first-page": "449", "article-title": "Lipid rafts mediate epigallocatechin-3-gallate- and green tea extract-dependent viability of human colon adenocarcinoma COLO 205 cells; clusterin affects lipid rafts-associated signaling pathways", "volume": "62", "author": "Pajak", "year": "2011", "journal-title": "J Physiol Pharmacol"}, {"key": "10.1002/ar.23498-BIB0022|ar23498-cit-0022", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1016/j.juro.2014.02.047", "article-title": "Autologous muscle derived cells for treatment of stress urinary incontinence in women", "volume": "192", "author": "Peters", "year": "2014", "journal-title": "J Urol"}, {"key": "10.1002/ar.23498-BIB0023|ar23498-cit-0023", "doi-asserted-by": "crossref", "first-page": "1275", "DOI": "10.1083/jcb.125.6.1275", "article-title": "Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy", "volume": "125", "author": "Rando", "year": "1994", "journal-title": "J Cell Biol"}, {"key": "10.1002/ar.23498-BIB0024|ar23498-cit-0024", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1111/j.1439-0264.2004.00575.x", "article-title": "Stereological study of the external urethral sphincter in the female urethra of the lamb: A new model for studies on urinary continence", "volume": "34", "author": "Rodriguez-Veiga", "year": "2005", "journal-title": "Anat Histol Embryol"}, {"key": "10.1002/ar.23498-BIB0025|ar23498-cit-0025", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1016/j.ydbio.2006.02.022", "article-title": "Satellite-cell pool size does matter: Defining the myogenic potency of aging skeletal muscle", "volume": "294", "author": "Shefer", "year": "2006", "journal-title": "Dev Biol"}, {"key": "10.1002/ar.23498-BIB0026|ar23498-cit-0026", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1159/000046188", "article-title": "Sphincteric musculature of female canine urethra in comparison to woman including 3D reconstruction", "volume": "170", "author": "Stolzenburg", "year": "2002", "journal-title": "Cells Tissues Organs"}, {"key": "10.1002/ar.23498-BIB0027|ar23498-cit-0027", "doi-asserted-by": "crossref", "first-page": "624", "DOI": "10.1016/j.urology.2005.09.055", "article-title": "Histomorphology of canine urethral sphincter systems, including three-dimensional reconstruction and magnetic resonance imaging", "volume": "67", "author": "Stolzenburg", "year": "2006", "journal-title": "Urology"}, {"key": "10.1002/ar.23498-BIB0028|ar23498-cit-0028", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1007/s10616-010-9306-9", "article-title": "A modified enrichment protocol for adult caprine skeletal muscle stem cell", "volume": "62", "author": "Tripathi", "year": "2010", "journal-title": "Cytotechnology"}, {"key": "10.1002/ar.23498-BIB0029|ar23498-cit-0029", "doi-asserted-by": "crossref", "first-page": "809", "DOI": "10.1590/1677-553820133806809", "article-title": "Is a sequence of tests during urethral pressure profilometry correlated with symptoms assessment in women?", "volume": "38", "author": "Valentini", "year": "2012", "journal-title": "Int Braz J Urol"}, {"key": "10.1002/ar.23498-BIB0030|ar23498-cit-0030", "first-page": "366", "article-title": "A quick, simple and unbiased method to quantify C2C12 myogenic differentiation", "volume": "44", "author": "Velica", "year": "2011", "journal-title": "Muscle Nerve"}, {"key": "10.1002/ar.23498-BIB0031|ar23498-cit-0031", "doi-asserted-by": "crossref", "first-page": "1065", "DOI": "10.1111/j.1939-1676.2006.tb00703.x", "article-title": "Vestibular, vaginal, and urethral relations in spayed dogs with and without lower urinary tract signs", "volume": "20", "author": "Wang", "year": "2006", "journal-title": "J Vet Intern Med"}, {"key": "10.1002/ar.23498-BIB0032|ar23498-cit-0032", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.5966/sctm.2014-0114", "article-title": "The dose-effect safety profile of skeletal muscle precursor cell therapy in a dog model of intrinsic urinary sphincter deficiency", "volume": "4", "author": "Williams", "year": "2015", "journal-title": "Stem Cells Transl Med"}, {"key": "10.1002/ar.23498-BIB0033|ar23498-cit-0033", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.3389/fnagi.2015.00085", "article-title": "Myogenic-specific ablation of Fgfr1 impairs FGF2-mediated proliferation of satellite cells at the myofiber niche but does not abolish the capacity for muscle regeneration", "volume": "7", "author": "Yablonka-Reuveni", "year": "2015", "journal-title": "Front Aging Neurosci"}, {"key": "10.1002/ar.23498-BIB0034|ar23498-cit-0034", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1262/jrd.20175", "article-title": "Satellite cell differentiation in goat skeletal muscle single fiber culture", "volume": "55", "author": "Yamanouchi", "year": "2009", "journal-title": "J Reprod Dev"}, {"key": "10.1002/ar.23498-BIB0035|ar23498-cit-0035", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1262/jrd.18094", "article-title": "Myogenic and adipogenic properties of goat skeletal muscle stem cells", "volume": "53", "author": "Yamanouchi", "year": "2007", "journal-title": "J Reprod Dev"}, {"key": "10.1002/ar.23498-BIB0036|ar23498-cit-0036", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1007/s00429-003-0313-x", "article-title": "The regeneration process of the striated urethral sphincter involves activation of intrinsic satellite cells", "volume": "206", "author": "Yiou", "year": "2003", "journal-title": "Anat Embryol (Berl)"}, {"key": "10.1002/ar.23498-BIB0037|ar23498-cit-0037", "doi-asserted-by": "crossref", "first-page": "4684", "DOI": "10.2527/jas.2012-5804", "article-title": "Porcine satellite cells are restricted to a phenotype resembling their muscle origin", "volume": "91", "author": "Zhu", "year": "2013", "journal-title": "J Anim Sci"}, {"key": "10.1002/ar.23498-BIB0038|ar23498-cit-0038", "doi-asserted-by": "crossref", "first-page": "2729", "DOI": "10.1016/j.juro.2006.07.135", "article-title": "The striated urethral sphincter of the pig shows morphological and functional characteristics essential for the evaluation of treatments for sphincter insufficiency", "volume": "176", "author": "Zini", "year": "2006", "journal-title": "J Urol"}], "container-title": ["The Anatomical Record"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Far.23498", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/ar.23498/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 25]], "date-time": "2017-06-25T01:11:34Z", "timestamp": 1498353094000}, "score": 17.39752, "subtitle": ["Caprine female urethra and caprine cells"], "issued": {"date-parts": [[2016, 11, 25]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[2017, 3]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/ar.23498", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1932-8486"], "issn-type": [{"value": "1932-8486", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 8, 15]], "date-time": "2018-08-15T09:02:40Z", "timestamp": 1534323760930}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Res"], "published-print": {"date-parts": [[2005, 4, 1]]}, "DOI": "10.1158/0008-5472.can-04-3309", "type": "journal-article", "created": {"date-parts": [[2005, 9, 15]], "date-time": "2005-09-15T21:52:59Z", "timestamp": 1126821179000}, "page": "2840-2845", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Carboxyl-Terminal Src Kinase Homologous Kinase Negatively Regulates the Chemokine Receptor CXCR4 through YY1 and Impairs CXCR4/CXCL12 (SDF-1\u03b1)\u2013Mediated Breast Cancer Cell Migration"], "prefix": "10.1158", "volume": "65", "author": [{"given": "Byeong-Chel", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "Tae-Hee", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Shalom", "family": "Avraham", "sequence": "additional", "affiliation": []}, {"given": "Anny", "family": "Usheva", "sequence": "additional", "affiliation": []}, {"given": "Hava Karsenty", "family": "Avraham", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2005, 4, 1]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-04-3309", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 21]], "date-time": "2017-07-21T22:43:57Z", "timestamp": 1500677037000}, "score": 17.39752, "issued": {"date-parts": [[2005, 4, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2005, 4, 1]]}, "published-print": {"date-parts": [[2005, 4, 1]]}, "issue": "7"}, "alternative-id": ["10.1158/0008-5472.CAN-04-3309"], "URL": "http://dx.doi.org/10.1158/0008-5472.can-04-3309", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T15:10:02Z", "timestamp": 1542813002849}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1998, 3, 1]], "date-time": "1998-03-01T00:00:00Z", "timestamp": 888710400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Dermatological Science"], "published-print": {"date-parts": [[1998, 3]]}, "DOI": "10.1016/s0923-1811(98)83306-9", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T03:04:12Z", "timestamp": 1027652652000}, "page": "S52", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Enhancement of antiangiogenic and antineoplastic activity of IL-12 by the combination with calcitriol"], "prefix": "10.1016", "volume": "16", "author": [{"given": "Dorota", "family": "Nowicka", "sequence": "first", "affiliation": []}, {"given": "Radoslaw", "family": "Zagozdzon", "sequence": "additional", "affiliation": []}, {"given": "Slawomir", "family": "Majewski", "sequence": "additional", "affiliation": []}, {"given": "Maria", "family": "Marczak", "sequence": "additional", "affiliation": []}, {"given": "Werner", "family": "Bollag", "sequence": "additional", "affiliation": []}, {"given": "Stefania", "family": "Jablonska", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Dermatological Science"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0923181198833069?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0923181198833069?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T14:33:28Z", "timestamp": 1542810808000}, "score": 17.39752, "issued": {"date-parts": [[1998, 3]]}, "references-count": 0, "alternative-id": ["S0923181198833069"], "URL": "http://dx.doi.org/10.1016/s0923-1811(98)83306-9", "ISSN": ["0923-1811"], "issn-type": [{"value": "0923-1811", "type": "print"}], "subject": ["Biochemistry", "Molecular Biology", "Dermatology"]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "ZAGOZDZON RADOSLAW"}